KR100895969B1 - Development of concentrated onion extract having antioxidant and anticholesterol activities - Google Patents
Development of concentrated onion extract having antioxidant and anticholesterol activities Download PDFInfo
- Publication number
- KR100895969B1 KR100895969B1 KR1020080057639A KR20080057639A KR100895969B1 KR 100895969 B1 KR100895969 B1 KR 100895969B1 KR 1020080057639 A KR1020080057639 A KR 1020080057639A KR 20080057639 A KR20080057639 A KR 20080057639A KR 100895969 B1 KR100895969 B1 KR 100895969B1
- Authority
- KR
- South Korea
- Prior art keywords
- onion
- concentrate
- onion extract
- extract concentrate
- cholesterol
- Prior art date
Links
- 229940072113 onion extract Drugs 0.000 title claims abstract description 51
- 230000000694 effects Effects 0.000 title abstract description 37
- 230000003078 antioxidant effect Effects 0.000 title abstract description 28
- 239000003963 antioxidant agent Substances 0.000 title abstract description 21
- 230000003627 anti-cholesterol Effects 0.000 title abstract description 14
- 238000011161 development Methods 0.000 title description 2
- 241000234282 Allium Species 0.000 claims abstract description 186
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims abstract description 186
- 239000012141 concentrate Substances 0.000 claims abstract description 165
- 239000000796 flavoring agent Substances 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 37
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 16
- 206010003210 Arteriosclerosis Diseases 0.000 claims abstract description 14
- 208000011775 arteriosclerosis disease Diseases 0.000 claims abstract description 14
- 235000013376 functional food Nutrition 0.000 claims abstract description 12
- 230000036541 health Effects 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 208000031226 Hyperlipidaemia Diseases 0.000 claims abstract description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 7
- 230000002265 prevention Effects 0.000 claims abstract description 7
- 230000006872 improvement Effects 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- 241000202807 Glycyrrhiza Species 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 5
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 5
- 240000002045 Guettarda speciosa Species 0.000 claims description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 5
- 238000010411 cooking Methods 0.000 claims description 5
- 229940010454 licorice Drugs 0.000 claims description 5
- 230000005070 ripening Effects 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 210000000056 organ Anatomy 0.000 claims 1
- 210000004197 pelvis Anatomy 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 58
- 235000019634 flavors Nutrition 0.000 abstract description 37
- 210000004369 blood Anatomy 0.000 abstract description 30
- 239000008280 blood Substances 0.000 abstract description 30
- 235000012000 cholesterol Nutrition 0.000 abstract description 22
- 150000002978 peroxides Chemical class 0.000 abstract description 11
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 7
- 150000003626 triacylglycerols Chemical class 0.000 abstract description 7
- 230000007760 free radical scavenging Effects 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 238000003860 storage Methods 0.000 description 51
- 239000000523 sample Substances 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 239000000203 mixture Substances 0.000 description 25
- 238000012360 testing method Methods 0.000 description 25
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 19
- 238000004458 analytical method Methods 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 18
- 238000002474 experimental method Methods 0.000 description 18
- 230000003247 decreasing effect Effects 0.000 description 15
- 235000013305 food Nutrition 0.000 description 15
- 230000001953 sensory effect Effects 0.000 description 15
- 235000005911 diet Nutrition 0.000 description 14
- 235000006708 antioxidants Nutrition 0.000 description 13
- 230000037213 diet Effects 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- -1 acupuncture Substances 0.000 description 12
- 235000019640 taste Nutrition 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Natural products CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 11
- 239000002994 raw material Substances 0.000 description 11
- 108010023302 HDL Cholesterol Proteins 0.000 description 10
- 241000700159 Rattus Species 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 239000000902 placebo Substances 0.000 description 10
- 229940068196 placebo Drugs 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 9
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 9
- 238000010171 animal model Methods 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 235000005875 quercetin Nutrition 0.000 description 9
- 229960001285 quercetin Drugs 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 8
- 108010093894 Xanthine oxidase Proteins 0.000 description 8
- 102100033220 Xanthine oxidase Human genes 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 8
- 235000009200 high fat diet Nutrition 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000008214 LDL Cholesterol Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000002000 scavenging effect Effects 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 102000019197 Superoxide Dismutase Human genes 0.000 description 6
- 108010012715 Superoxide dismutase Proteins 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 6
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 6
- 229930003935 flavonoid Natural products 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 235000017173 flavonoids Nutrition 0.000 description 6
- 230000037406 food intake Effects 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 230000002906 microbiologic effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 235000019750 Crude protein Nutrition 0.000 description 5
- 108010028554 LDL Cholesterol Proteins 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 150000001491 aromatic compounds Chemical class 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000004817 gas chromatography Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 5
- 229910052753 mercury Inorganic materials 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 235000021003 saturated fats Nutrition 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- YGHRJJRRZDOVPD-UHFFFAOYSA-N 3-methylbutanal Chemical compound CC(C)CC=O YGHRJJRRZDOVPD-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- YWHLKYXPLRWGSE-UHFFFAOYSA-N Dimethyl trisulfide Chemical compound CSSSC YWHLKYXPLRWGSE-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- PUCHCUYBORIUSM-UHFFFAOYSA-N Methyl propyl disulfide Chemical compound CCCSSC PUCHCUYBORIUSM-UHFFFAOYSA-N 0.000 description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 229960002708 antigout preparations Drugs 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000001465 calcium Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 235000019784 crude fat Nutrition 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 229910017604 nitric acid Inorganic materials 0.000 description 4
- 150000002989 phenols Chemical class 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 235000021080 saturated-trans fats Nutrition 0.000 description 4
- 229940075420 xanthine Drugs 0.000 description 4
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 3
- QXFMGXHGOGVHGY-UHFFFAOYSA-N 2,4-dimethylthiophene Chemical compound CC=1SC=C(C1)C.CC=1SC=C(C1)C QXFMGXHGOGVHGY-UHFFFAOYSA-N 0.000 description 3
- OUDFNZMQXZILJD-UHFFFAOYSA-N 5-methyl-2-furaldehyde Chemical compound CC1=CC=C(C=O)O1 OUDFNZMQXZILJD-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 201000005569 Gout Diseases 0.000 description 3
- 208000000501 Lipidoses Diseases 0.000 description 3
- 206010024585 Lipidosis Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 238000004737 colorimetric analysis Methods 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical class [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 235000021579 juice concentrates Nutrition 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- CPULIKNSOUFMPL-UHFFFAOYSA-N 2,4-0Dimethylthlthiophene Natural products CC1=CSC(C)=C1 CPULIKNSOUFMPL-UHFFFAOYSA-N 0.000 description 2
- BYGQBDHUGHBGMD-UHFFFAOYSA-N 2-methylbutanal Chemical compound CCC(C)C=O BYGQBDHUGHBGMD-UHFFFAOYSA-N 0.000 description 2
- QENGPZGAWFQWCZ-UHFFFAOYSA-N 3-Methylthiophene Chemical compound CC=1C=CSC=1 QENGPZGAWFQWCZ-UHFFFAOYSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005730 Azoxystrobin Substances 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 238000007696 Kjeldahl method Methods 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000186779 Listeria monocytogenes Species 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 229910052785 arsenic Inorganic materials 0.000 description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- DFBKLUNHFCTMDC-PICURKEMSA-N dieldrin Chemical compound C([C@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@H]2[C@@H]2[C@H]1O2 DFBKLUNHFCTMDC-PICURKEMSA-N 0.000 description 2
- 229950006824 dieldrin Drugs 0.000 description 2
- NGPMUTDCEIKKFM-UHFFFAOYSA-N dieldrin Natural products CC1=C(Cl)C2(Cl)C3C4CC(C5OC45)C3C1(Cl)C2(Cl)Cl NGPMUTDCEIKKFM-UHFFFAOYSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- ALVPFGSHPUPROW-UHFFFAOYSA-N dipropyl disulfide Chemical compound CCCSSCCC ALVPFGSHPUPROW-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- DFBKLUNHFCTMDC-GKRDHZSOSA-N endrin Chemical compound C([C@@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@@H]2[C@H]2[C@@H]1O2 DFBKLUNHFCTMDC-GKRDHZSOSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000002470 solid-phase micro-extraction Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003464 sulfur compounds Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 229930013915 (+)-catechin Natural products 0.000 description 1
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- 239000001893 (2R)-2-methylbutanal Substances 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- IEMMBWWQXVXBEU-UHFFFAOYSA-N 2-acetylfuran Chemical compound CC(=O)C1=CC=CO1 IEMMBWWQXVXBEU-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 238000010953 Ames test Methods 0.000 description 1
- 231100000039 Ames test Toxicity 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- BPKOOYZZEUQWIB-UHFFFAOYSA-N CC1=CSC=C1.CC1=CSC=C1 Chemical compound CC1=CSC=C1.CC1=CSC=C1 BPKOOYZZEUQWIB-UHFFFAOYSA-N 0.000 description 1
- 208000022306 Cerebral injury Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 241000533367 Cnidium officinale Species 0.000 description 1
- 241000209205 Coix Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000020881 DASH diet Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- GAZXPZNJTZIGBO-UHFFFAOYSA-N Dipropyl trisulfide Chemical compound CCCSSSCCC GAZXPZNJTZIGBO-UHFFFAOYSA-N 0.000 description 1
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical compound COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 235000006964 Perilla frutescens var acuta Nutrition 0.000 description 1
- 240000001979 Perilla frutescens var. acuta Species 0.000 description 1
- 235000003893 Prunus dulcis var amara Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 241000015177 Saccharina japonica Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000000923 atherogenic effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000001211 electron capture detection Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000013095 identification testing Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- JBXYCUKPDAAYAS-UHFFFAOYSA-N methanol;trifluoroborane Chemical compound OC.FB(F)F JBXYCUKPDAAYAS-UHFFFAOYSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000003303 reheating Methods 0.000 description 1
- 230000012191 relaxation of muscle Effects 0.000 description 1
- 230000033904 relaxation of vascular smooth muscle Effects 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 235000000891 standard diet Nutrition 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 150000003577 thiophenes Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Seasonings (AREA)
Abstract
본 발명은 양파추출농축액 및 그의 제조방법에 관한 것으로, 보다 구체적으로는 천연조향제를 함유하는 항산화 및 항콜레스테롤 활성을 갖는 양파추출 농축액 및 양파특유의 불쾌치를 차폐하고 농축시 강화되는 단맛을 억제하는 양파추출농축액의 제조방법에 관한 것이다. 본 발명의 양파추출 농축액은 혈중 중성지방 및 혈중 콜레스테롤을 유의적으로 감소시켜 고지혈증 및 동맥경화를 예방 및 개선할 수 있으며, 디페닐 피크릴히드라질 자유기 소거능 및 과산소디스뮤타제유사 활성을 높임으로써 항산화효과 및 항콜레스테롤 효과를 가진다. 따라서 본 발명의 양파추출농축액은 산화 관련 질환 및 콜레스테롤 관련 질환의 예방 또는 개선을 위한 약학조성물 및 건강기능성 식품으로 유용하게 이용될 수 있다.The present invention relates to an onion extract concentrate and a method for preparing the same, more specifically, to extract the onion extract concentrate having antioxidant and anti-cholesterol activity containing natural flavoring agent and onion-specific unpleasant and to suppress the sweetness strengthened when concentrated It relates to a method for producing onion extract concentrate. Onion extract concentrate of the present invention can significantly reduce blood triglycerides and blood cholesterol to prevent and improve hyperlipidemia and arteriosclerosis, and to enhance diphenyl picrylhydrazyl free radical scavenging activity and peroxide dismutase-like activity. As it has an antioxidant effect and an anticholesterol effect. Therefore, the onion extract concentrate of the present invention can be usefully used as a pharmaceutical composition and health functional food for the prevention or improvement of oxidation-related diseases and cholesterol-related diseases.
양파농축액, 천연조향제, 항산화, 항고지혈증, 항콜레스테롤 Onion concentrate, natural flavor, antioxidant, antihyperlipidemia, anticholesterol
Description
본 발명은 양파추출농축액 및 그 제조방법에 관한 것으로서, 보다 상세하게는 천연조향제를 함유하여 관능이 향상됨과 동시에 항산화 및 항콜레스테롤 활성을 갖는 양파추출농축액 및 그 제조방법에 관한 것이다.The present invention relates to an onion extract concentrate and a method for preparing the same, and more particularly, to a onion extract concentrate having an antioxidant and anti-cholesterol activity at the same time it contains a natural steering agent improves the organoleptic activity.
양파는 식생활에서 빼놓을 수 없는 중요한 향신 야채로서 조리에 직접 사용되어 왔으며, 가장 많은 빈도로 섭취되고 있는 야채 중의 하나이다. 양파는 당질(糖質), 인분(燐分), 칼슘, 염분, 비타민 B1, 비타민 C등이 함유되어 있고, 스테미너 강화, 혈관 강화, 항알레르기 작용 및 육류나 계란 그리고 우유 등 동물성 단백질의 과식에 의한 '암모니아 피로'라고 하는 고기의 독을 해독시키는데 효과가 있는 것으로 널리 알려져 있으며, 건강식품으로 식용되고 있다.Onions are an important spices that are indispensable in the diet and have been used directly in cooking and are one of the most frequently eaten vegetables. Onions contain carbohydrates, phosphorus, calcium, salt, vitamin B1, vitamin C, etc., and are used for stamina strengthening, blood vessel strengthening, anti-allergic activity, and overeating of animal proteins such as meat, eggs, and milk. It is widely known to be effective in detoxifying the poison of meat called 'ammonia fatigue', and is being eaten as a health food.
이와 같은 양파를 보다 용이하게 섭취하기 위하여 양파 추출물이나 고농축 추출물이 개발되었다.Onion extracts or highly concentrated extracts have been developed to more easily consume such onions.
그러나 종래의 양파추출물은 자극적인 맛과 특유의 냄새로 인해 쉽게 섭취하기가 힘들고, 섭취 후 입안에 양파 특유의 단맛이 장시간 잔존함으로써 건강식품임에도 불구하고 섭취를 꺼리게 되었다. However, the conventional onion extract is difficult to easily eat due to the irritating taste and peculiar smell, and after eating, it is reluctant to ingest despite being a health food because the sweetness of the onion remains in the mouth for a long time.
상기와 같은 양파추출물의 맛과 향의 문제를 해결하기 위한 노력이 많이 진행되고 있으며, 한국공개특허 10-2004-0080505호(양파고농축 추출물 제조방법)에서는 양파의 효소반응을 차단할 수 있도록 양파의 껍질을 벗기지 않은 채 냉동고에 넣어 동결시키는 동결공정과, 충분히 동결된 양파의 껍질을 제거하고 절삭기를 이용하여 소정크기로 세절하는 세절공정과, 동결상태인 세절된 양파를 고압솥에 넣어 가열하는 가열공정과, 충분히 가열된 양파 가열물을 냉각하고 통상의 압착기 및 여과기로 압착, 여과하여 양파 추출물을 얻는 추출공정과, 양파 추출물을 원심력으로 원심분리하여 고형물을 제거하는 고형물제거공정과, 고형물이 제거된 양파 추출물로부터 상등액만을 취하여 미세여과를 실시한 후 이를 포장하여 완성하는 공정으로 이루어진 양파고농축 추출물 제조방법이 공개되어 있다.Efforts have been made to solve the problems of flavor and aroma of onion extracts as described above, and Korean Laid-open Patent No. 10-2004-0080505 (onion extract concentrate method) to peel onions so that the enzyme reaction of onions Freezing process to freeze without removing the skin, freezing process to remove enough frozen onion peel and cut to a predetermined size using a cutting machine, heating to put the frozen onions in the autoclave to heat Process, an extraction process of cooling the sufficiently heated onion heating material, compressing and filtration with a conventional presser and a filter to obtain onion extracts, and removing the solids by centrifuging the onion extracts by centrifugal force, and removing the solids. It is an onion which consists of taking the supernatant from the extracted onion extract and carrying out microfiltration Axis is an extract method is disclosed.
그러나 기존의 양파추출농축액 역시 양파특유의 불쾌치를 차폐하고 양파즙 농축시 강화되는 단맛을 억제하지는 못하며, 양파추출농축액의 정확한 생리활성에 대한 연구를 통한 양파추출농축액의 기능성 규명이 되어 있지 않은 실정이다.However, the existing onion extract concentrates also do not inhibit the onion's peculiar discomfort and do not inhibit the sweetness that is enhanced when the onion juice concentrates, and the functionalities of the onion extract concentrates have not been investigated by studying the exact physiological activity of the onion extract concentrates. .
본 발명의 목적은 천연조향제를 함유하는 항산화 및 항콜레스테롤 활성을 갖는 양 파추출농축액을 제공하는 것이다. It is an object of the present invention to provide a sheep leek extract concentrate having antioxidant and anti-cholesterol activity, which contains a natural steering agent.
본 발명의 또 다른 목적은 상기 항산화 및 항콜레스테롤 활성을 가지며, 양파고유의 불쾌치를 차폐하고 농축시 강화되는 단맛을 억제하는 양파추출농축액의 제조방법을 제공하는 것이다.Still another object of the present invention is to provide a method for preparing an onion extract concentrate having the antioxidant and anti-cholesterol activity and shielding the unpleasantness of onion-specific and inhibiting the sweetness which is enhanced upon concentration.
상기의 목적을 달성하기 위해서, 본 발명은 천연조향제를 함유하는 항산화 및 항콜레스테롤 활성을 갖는 양파추출농축액을 제공한다. In order to achieve the above object, the present invention provides an onion extract concentrate having antioxidant and anti-cholesterol activity containing a natural steering agent.
또한, 본 발명은 상기 항산화 활성 및 항콜레스테롤 활성을 가지고, 양파고유의 불쾌치를 차폐하고 농축시 강화되는 단맛을 억제하는 양파추출농축액의 제조방법을 제공한다.The present invention also provides a method for producing an onion extract concentrate having the antioxidant activity and the anti-cholesterol activity, shielding the unpleasantness of onion-specific and suppressing the sweetness that is enhanced when concentrated.
또한 본 발명은 상기 방법에 의해 제조된 양파추출농축액을 함유하는 고지혈증 또는 동맥경화의 예방 및 치료용 건강기능식품을 제공한다.The present invention also provides a health functional food for the prevention and treatment of hyperlipidemia or arteriosclerosis containing onion extract concentrate prepared by the above method.
이하, 본 발명을 자세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 제 1 견지에 의하면, 본 발명은 천연조향제를 함유하는 항산화 및 항콜레스테롤 활성을 갖는 양파추출농축액을 제공한다.According to the first aspect of the present invention, the present invention provides an onion extract concentrate having antioxidant and anti-cholesterol activity containing a natural steering agent.
상기 천연조향제는 감초, 당귀, 갈근, 천궁, 소엽 및 다시마가 동일비율로 조합된 것으로, 양파와 가장 조화를 이루는 친환경적인 농산물로써 관능적인 품질의 향상 및 특정 생리작용 상승효과를 기대 할 수 있으며, 양파의 단맛을 상쇄시켜줄 수 있는 관능특성을 지닌다. The natural flavoring agent is a combination of licorice, Angelica, brown root, cheonggung, lobules and kelp in the same ratio, the most environmentally friendly agricultural products in harmony with the onion can be expected to improve the sensory quality and specific physiological synergistic effect It has sensory properties that can counteract the sweetness of onions.
본 발명의 양파추출농축액은 관능검사 결과 10 내지 21 브릭스(oBrix)의 양파농축정도가 바람직하며, 15 브릭스(oBrix)의 양파농축정도가 더욱 바람직하다. Onion extract concentrate of this invention is the onion concentrations of sensory evaluation, 10 to 21 Brix (Brix o) Preferably, it is a more preferred amount of onion concentrate 15 Brix (o Brix).
본 발명의 천연조향제는, 양파무게에 대하여 양파무게 대비 0.2~1.0 중량% 함유하는 것이 바람직하며, 0.5%를 포함하는 것이 가장 바람직하다. Natural flavoring agent of the present invention, it is preferable to contain 0.2 to 1.0% by weight relative to the onion weight, with respect to onion weight, it is most preferable to contain 0.5%.
또한, 본 발명의 제 2 견지에 의하면, 본 발명은 양파를 선별하여 수세 및 세절한 후, 천연조향제를 첨가하여 자숙하는 단계; 및 상기 자숙액을 여과하고, 상기 여과된 자숙액을 농축하는 단계;를 포함하여 이루어지는, 양파 고유의 불쾌치를 차폐하고 양파의 단맛이 억제된 양파추출농축액의 제조방법을 제공한다.In addition, according to a second aspect of the present invention, the present invention is the step of washing and washing the onions and washing, then adding a natural steering agent to ripening; And filtering the cooked liquid and concentrating the filtered cooked liquid. The method provides a method for preparing an onion extract concentrate, which comprises the onion-induced indigestion and the sweetness of the onion is suppressed.
본 발명에 있어서, 양파를 선별하고 이물질 제거를 위하여 충분히 수세 한 후 세절하고, 상기 세절은 슬라이스 커터 사용 등 일상적인 세절방법이 모두 가능하다. In the present invention, the onion is screened and rinsed after washing with water sufficiently to remove the foreign matter, and the chopped may be all the usual slicing methods such as using a slice cutter.
또한, 본 발명에 있어서, 상기 세절된 양파를 천연조향제와 함께 91~99℃의 온도로 4~6시간 스팀을 이용하여 자숙하여 가열추출하는 것이 바람직하다. 상기 자숙은 96-99℃에서 5-6시간 동안 가열추출하는 것이 더욱 바람직하다. 본 발명의 일 실시예에서는 상기 가열추출에 의한 자숙은 이중증기솥을 이용하였다.In addition, in the present invention, it is preferable to heat and extract the minced onion by using steam for 4-6 hours at a temperature of 91 ~ 99 ℃ with a natural steering agent. More preferably, the cooked food is heat-extracted at 96-99 ° C. for 5-6 hours. In one embodiment of the present invention, the self-cooking by the heat extraction used a double steam pot.
또한, 본 발명에 있어서, 상기 자숙액의 여과는 여과된 잔사를 체반을 이용하여 여과하는 단계를 더 포함할 수 있다. In addition, in the present invention, the filtering of the cooked liquid may further include the step of filtering the filtered residue by using a bed.
또한, 본 발명에 있어서, 상기 여과된 자숙액은 91~99℃의 온도로 스팀을 이용하여 농축하는 것이 바람직하다. 상기 농축은 양파추출농축액의 농도가 10~21 브릭스(oBrix)가 되도록 농축하는 것이 바람직하며, 가장 바람직하게는 상기 농축은 96~99℃에서 농도가 15브릭스가 되도록 농축하는 것이 좋다. 본 발명의 일 실시예에서는 상기 농축은 이중증기솥을 이용하였다. In addition, in the present invention, it is preferable that the filtered cooking liquid is concentrated using steam at a temperature of 91 to 99 ° C. The concentration is preferably concentrated so that the concentration of the onion extract concentrate is 10 ~ 21 Brix ( o Brix), most preferably the concentration is concentrated so that the concentration is 15 Brix at 96 ~ 99 ℃. In one embodiment of the present invention the concentration was used a double steamer.
본 발명의 양파추출농축액은 액체 상태로 제조될 수도 있으며, 분무건조 등을 통한 분말형태로도 변형가능하며, 환제, 과립, 침제, 정제, 캡슐 또는 음료 등의 다양한 형태로 사용할 수 있다.The onion extract concentrate of the present invention may be prepared in a liquid state, can be transformed into a powder form through spray drying, etc., can be used in various forms such as pills, granules, acupuncture, tablets, capsules or beverages.
본 발명의 양파추출농축액은 대표적인 플라보노이드 물질로 항암효과, 흡연으로 인해 발생하는 스트레스 단백질의 생성 억제, 동맥경화방지 및 혈관평활근을 이완시켜서 혈압을 낮추거나 부정맥을 억제하는 효과 등 다양한 생리적 기능성을 기대할 수 있는 성분인 퀘세틴 (quercetin)을 제조과정을 통하여 안정적으로 유지함으로써 제조공정의 표준화 기준을 확립하였다. 퀘세틴이 양파에서는 15.28~17.63 mg/100g의 함량을 나타내었으며, 자숙 및 여과과정 후 9.42~12.66mg/100g을 가졌고 농축 과정을 통하여 17.22~24.52mg/100g을 유지함을 3번의 반복 실험을 통하여 확인하였다.The onion extract concentrate of the present invention can be expected to have various physiological functionalities such as anti-cancer effect, suppression of production of stress protein caused by smoking, prevention of arteriosclerosis, and relaxation of vascular smooth muscle by reducing the blood pressure or arrhythmia as a representative flavonoid material. Quercetin (quercetin) that is present in the manufacturing process by maintaining a stable standard was established. Quercetin showed 15.28 ~ 17.63 mg / 100g content in onion, and it had 9.42 ~ 12.66mg / 100g after ripening and filtration and maintained 17.22 ~ 24.52mg / 100g through concentration. It was.
본 발명의 양파추출농축액의 일반성분을 미국공인분석화학회(Association of official analytical chemists, AOAC)법에 따라 수분은 상압 가열건조법, 조회 분은 직접 회분법, 조지방은 soxhlet법, 조단백질은 semi-micro kjeldahl법, 식이섬유는 식품공전에 따라 분석한 결과 양파농축액 100g 당 수분 86.0~86.1%, 조회분 0.7~0.8%, 조지방 0.6~1.6%, 조단백질 1.2~1.6%, 식이섬유 0.98~1.15%로 나타났다. The general composition of the onion extract concentrate of the present invention according to the Association of official analytical chemists (AOAC) method, moisture is the atmospheric pressure drying method, inquiries are direct ash method, crude fat is soxhlet method, crude protein is semi-micro The kjeldahl method and dietary fiber were analyzed according to Food Code, and water content of 86.0 ~ 86.1%, crude ash 0.7 ~ 0.8%, crude fat 0.6 ~ 1.6%, crude protein 1.2 ~ 1.6%, dietary fiber 0.98 ~ 1.15% per 100g of onion concentrate. .
포화지방 및 트랜스 지방 함유량 분석은 식품의약품안전청 식품위생검사기관인 계명대학교 전통미생물자원연구센터에서 실시하였으며, 본 발명의 양파농축액에서는 영양성분인 포화지방, 트랜스지방 및 콜레스테롤이 검출되지 않았다. Saturated fat and trans fat content analysis was carried out at Keimyung University Traditional Microbiological Resources Research Center, Food Hygiene Testing Agency of the Korea Food and Drug Administration. Onion concentrate of the present invention was not detected nutrients saturated fat, trans fat and cholesterol.
대표적인 항산화물질인 페놀화합물은 10.68~13.93 mg/mL로 함유되어 있으며, 양파농축액의 저장기간에 따라 일정하게 유지되었고, 일반무기질원소 칼슘, 철, 칼륨, 인, 나트륨 및 아연의 경우 3회의 실험에 걸친 실험결과 유사한 구성비를 가짐으로써 본 양파농축액 제조공정의 안정성을 나타낸다.Phenolic compound, which is a representative antioxidant, is contained in 10.68 ~ 13.93 mg / mL, and it is kept constant according to the storage period of onion concentrate. In the case of general inorganic elements calcium, iron, potassium, phosphorus, sodium and zinc in three experiments Experimental results show that the composition of this onion concentrate is stable by having similar composition ratio.
본 발명에 따른 양파추출농축액의 저장기간에 따른 저장안정성의 검증은 식품의약품안전청 식품위생검사기관인 계명대학교 전통미생물자원연구센터에서 실시하였으며, 미생물 및 중금속 함량 등 모든 분야에서 본 발명의 양파농축액의 저장안정성이 확인되었다. 또한 저장기간 중 산도와 색도의 측정 및 차이식별검사를 통한 품질변화를 측정한 결과 30℃에서 120일간 저장동안 유의적인 품질저하현상은 관찰되지 않았다.The storage stability of the onion extract concentrate according to the present invention was verified at the traditional microbial resource research center of Keimyung University, which is a food hygiene testing agency of the Korea Food and Drug Administration, and stored the onion concentrate of the present invention in all fields including microorganisms and heavy metal content. Stability was confirmed. In addition, no significant degradation was observed during storage for 120 days at 30 ° C.
또한, 본 발명의 제 3 견지에 의하면, 본 발명은 상기 제조방법에 따라 제조되고, 양파고유치의 불쾌치를 차폐하고 양파의 단맛이 억제된, 항산화 및 항 콜레스테롤 활성을 갖는 양파추출농축액을 제공한다.In addition, according to a third aspect of the present invention, the present invention provides an onion extract concentrate having antioxidant and anti-cholesterol activity, prepared according to the above production method, shielding the unpleasant odor of onion high value and suppressing the sweetness of onion.
또한, 본 발명의 제 4 견지에 의하면, 본 발명은 상기 양파추출농축액을 유효성분으로 함유하는 고지혈증 또는 동맥경화의 예방 또는 개선용 건강기능식품을 제공한다.In addition, according to a fourth aspect of the present invention, the present invention provides a health functional food for preventing or improving hyperlipidemia or arteriosclerosis containing the onion extract concentrate as an active ingredient.
또한 본 발명의 제 5 견지에 의하면, 본 발명은 양파추출농축액을 유효성분으로 함유하는 고지혈증 또는 동맥경화의 예방 또는 개선용 약학적 조성물을 제공한다.In addition, according to a fifth aspect of the present invention, the present invention provides a pharmaceutical composition for preventing or improving hyperlipidemia or arteriosclerosis containing onion extract concentrate as an active ingredient.
본 발명의 일 실시예에서는, 상기 본 발명의 양파추출농축액의 기능성 규명을 위하여 디페닐 피크릴히드라질 자유기 소거능 (2,2-diphenyl-1-picrylhydrazyl radical scavenging effect) 및 과산소디스뮤타제(Superoxide dismutase, SOD) 활성측정을 통한 항산화실험 및 크산틴 옥시다테(xanthine oxidase) 저해활성 측정을 통한 항통풍실험을 실시하였으며, 고지방 식이로 유도된 흰쥐의 고지혈증 동물모델을 활용하여 양파추출농축액의 고지혈증 완화 효과를 실험하였다. In one embodiment of the present invention, diphenyl picrylhydrazyl free group scavenging effect (2,2-diphenyl-1-picrylhydrazyl radical scavenging effect) and peroxide dismutase for the functional identification of the onion extract concentrate of the present invention ( Anti-gout experiments were carried out by measuring superoxide dismutase (SOD) activity and anti-gout tests by measuring xanthine oxidase inhibitory activity. The relaxation effect was tested.
디페닐 피크릴히드라질는 안정한 자유라디칼로서 디페닐 피크릴히드라질 자유기 소거능이 높으면 자유라디칼을 환원시키거나 상쇄시키는 능력이 높아 체내에 활성산소와 같은 자유라디칼의 소거작용으로 노화를 억제하는 효과를 나타내어 항산화 실험방법으로 선택하였다. 본 발명에 따른 양파추출농축액은 디페닐 피크릴히드라질 자유기 소거능 측정 결과 저장 100일까지 87~94%의 높은 소거능을 가졌고 150일 이후에는 다소 활성이 감소하여 81~85%의 활성을 나타내었다.Diphenyl picrylhydrazyl is a stable free radical, and when diphenyl picrylhydrazyl free radical scavenging ability is high, it has a high ability to reduce or offset free radicals, thereby suppressing aging effect by scavenging action of free radicals such as free radicals in the body. It was selected as the antioxidant test method. Onion extract concentrate according to the present invention had high scavenging ability of 87-94% until 100 days of storage as a result of diphenyl picrylhydrazyl free radical scavenging, and showed a decrease of activity after 81 days, showing 81-85% activity. .
생체내에는 활성산소에 의한 강한 산화력으로 생리적 장해를 일으킨다. 즉 산소는 1가 환원 반응시 중간 반응 물질로서 O2 -, H2O2, OH-이 생성되며 생체내 항산화 효소에 의해 체내에 무독한 물이 생성된다. 항산화 효소 중 과산소디스뮤타제(superoxide dismutase, SOD)는 O2 -, 를 H2O2로 전환시키는 촉매효소로 활성 산소에 대한 방어기작으로 중요한 역할을 한다. 본 발명의 양파추출농축액이 저장기간 동안 이러한 과산소 디스뮤타제의 활성을 40~49% 유지함으로, 저장 및 유통기간의 항산화 효과 유지를 통해 건강기능식품으로 사용될 수 있음을 확인하였다. In vivo, physiological disorders are caused by the strong oxidative power of free radicals. In other words the oxygen O 2 as an intermediate after the first reaction material is reduction -, H 2 O 2, OH - are generated, and the generated water is a non-toxic in vivo by in vivo antioxidant enzymes. Among the antioxidant enzymes, superoxide dismutase (SOD) is a catalytic enzyme that converts O 2 - to H 2 O 2 and plays an important role as a defense against free radicals. Onion extract of the present invention was confirmed that by maintaining the activity of these peroxygen dismutase 40-49% during the storage period, it can be used as a health functional food through maintaining the antioxidant effect of the storage and distribution period.
건강한 여대생들을 대상으로 하여 4주간 매일 150 ㎖의 양파농축액 섭취실험의 결과, 과산소디스뮤타제가 본 발명의 양파추출농축액 섭취 후에 유의적으로 증가하여 항산화효과를 확인할 수 있었다.As a result of 150 ml onion concentrate intake experiments daily for 4 weeks in healthy female college students, peroxide dismutase was significantly increased after ingestion of the onion extract concentrate of the present invention was confirmed an antioxidant effect.
통풍은 관절에 심한 염증이 되풀이하여 생기는 유전성 대사이상질환으로 관절 속이나 주위에 요산염이 쌓여서 일어난다. 통풍을 일이키는 효소로 크산틴 옥시다제(xanthine oxidase)가 크산틴(xanthine) 또는 히포크산틴(hypoxathine)으로부터 요산(uric acid)을 생성하여 통증을 유발 시키는 것으로 알려져 있다. 본 발명의 양파추출농축액의 크산틴 옥시다제 저해활성을 측정한 결과 14~16%정도로 항통풍성을 가짐을 확인하였으며, 저장 150일에도 9~12%의 효능을 보유함으로써 건강기능성 식품으로 기능할 수 있음을 실험적으로 입증하였다. Gout is a hereditary metabolic disorder caused by repeated inflammation of the joints, which is caused by the accumulation of urate in and around the joints. It is known that ganthine oxidase (xanthine oxidase) produces uric acid from xanthine or hypoxathine, causing pain. As a result of measuring xanthine oxidase inhibitory activity of the onion extract concentrate of the present invention, it was confirmed that it has anti-gout property of about 14 to 16%, and it can function as a health functional food by retaining the efficacy of 9 to 12% even in storage 150 days. Experimentally demonstrated.
본 발명의 최적의 실시예에 따른 0.5%의 천연조향제가 함유된 15 브릭 스(oBrix)의 양파추출농축액 각각 저농도군(1.63 mL/rat), 중농도군(3.26 mL/rat), 고농도군(6.52 mL/rat)을 6 주 동안 고지방식이와 공급한 결과 실험동물의 혈청중성지방과 콜레스테롤의 농도가 감소함을 볼 수 있었다. 이러한 결과는 고중성지방혈증(hypertriacylglycerolemia)을 특별한 의학적 도움 없이 식이처방(dietary approach)의 형태로 섭취함으로써 증상을 완화할 수 있으며, 본 발명에 따른 양파추출농축액은 고지방혈증을 완화한다는 것을 실험적으로 나타낸다.0.5% of natural steering I contains a 15-brick's onion extract concentrate, respectively the low concentration group (1.63 mL / rat), jungnong dogun (3.26 mL / rat), high-concentration group (o Brix) according to an optimal embodiment of the present invention ( 6.52 mL / rat) and high fat diet for 6 weeks showed that the serum triglyceride and cholesterol levels of the test animals decreased. These results experimentally indicate that taking hypertriacylglycerolemia in the form of a dietary approach without special medical assistance, and the onion extract concentrate according to the present invention alleviates hyperlipidemia. .
연세대학교 의과대학 세브란스병원에서 LDL 콜레스테롤 농도가 130 mg/dL 이상인 18세 이상 60세 이하 환자를 대상으로 임상시험을 통해, 본 발명에 따른 양파농축액 섭취 후 혈중 총 콜레스테롤 농도 및 LDL-콜레스테롤 농도가 유의적(p<0.01)으로 감소하여, 고지혈증을 완화시키며 동맥경화지수를 낮추는 것을 확인하였으며, 본 발명에 따른 양파추출농축액이 혈중지질 및 동맥경화의 예방 및 치료, 개선용 약학조성물 및 건강기능식품으로 사용될 수 있음을 나타낸다. In clinical trials of patients aged 18 to 60 with LDL cholesterol levels of 130 mg / dL or more at Yonsei University College of Medicine Severance Hospital, serum total cholesterol and LDL-cholesterol levels were significantly increased after ingestion of onion concentrate according to the present invention. It was confirmed that by reducing the enemy (p <0.01), relieves hyperlipidemia and lowers the arteriosclerosis index, the onion extract concentrate according to the present invention as a pharmaceutical composition and health functional food for the prevention and treatment of blood lipids and arteriosclerosis, improvement It can be used.
본 발명의 항산화 및 항콜레스테롤 활성을 갖는 양파추출농축액은 혈중 중성지방 및 혈중 콜레스테롤을 유의적으로 감소시켜 혈중지질과 동맥경화를 개선시킬 수 있으며, 디페닐 피크릴히드라질 자유기 소거능 (2,2-diphenyl-1-picrylhydrazyl radical scavenging effect) 및 과산소디스뮤타제 유사 활성을 높임으로써 항산화효과 및 항콜레스테롤 효과를 가진다. Onion extract concentrate having antioxidant and anti-cholesterol activity of the present invention can significantly reduce blood triglycerides and cholesterol and improve blood lipid and arteriosclerosis, and diphenyl picrylhydrazyl free radical scavenging ability (2,2 -diphenyl-1-picrylhydrazyl radical scavenging effect) and peroxide dismutase-like activity to enhance the antioxidant and anti-cholesterol effect.
뿐만 아니라, 본 발명의 양파추출농축액은 천연조향제를 함유하여 양파특유의 불쾌치를 차폐하고 양파즙 농축시 강화되는 단맛을 억제함으로써 산화 관련 질환 및 콜레스테롤 관련 질환의 예방 또는 개선을 위한 약학조성물 및 건강기능성 식품으로 유용하게 이용될 수 있다.In addition, the onion extract concentrate of the present invention contains a natural flavoring agent to shield the onion-specific discomfort and inhibit the sweetness strengthened when the onion juice concentrate by pharmacy composition and health for the prevention or improvement of oxidation-related diseases and cholesterol-related diseases It can be usefully used as a functional food.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예 및 실험예를 제시한다. 그러나 하기의 실시예 및 실험예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred examples and experimental examples are presented to help understand the present invention. However, the following Examples and Experimental Examples are provided only to more easily understand the present invention, and the contents of the present invention are not limited by the Examples.
<< 실시예Example 1 > 양파농축액의 제조 1> Preparation of Onion Concentrate
1-1. 천연조향제의 선별1-1. Selection of natural flavoring agents
천연조향제는 농산물 중에서 식품에 응용함으로써 관능적인 품질의 향상 및 특정 생리작용 상승효과를 기대 할 수 있는 물질로, 양파엑기스에 잠재적으로 기대되는 생리적 효과(항고지혈증 및 항콜레스테롤)와 관련되고 양파특유의 불쾌치를 차폐하고 양파즙 농축시 강화되는 단맛을 억제할 수 있는 천연조향제를 선별하였으며, 선별된 재료는 하기 표 1과 같다. Natural sterilizers are expected to improve sensory quality and certain physiological synergistic effects by applying them to foods from agricultural products.They are related to the potential physiological effects (antihyperlipidemia and anti-cholesterol) on onion extracts and are unique to onions. The natural flavoring agent was selected to shield the unpleasant value of and inhibit the sweetness that is enhanced when the onion juice is concentrated, the selected materials are shown in Table 1 below.
본 자료는 식품의약안전청, 식품원재료 자료검색 (2007)을 통한 것이며, 관능특성은 원료(50g)에 물(3500g)을 첨가하여 6시간 가열(93±3℃) 후 조향제를 제거한 후 100mL 정도로 농축한 시료를 제공하여 관능패널(3명)을 통한 관능묘사를 통하여 얻어진 것이다.This data is obtained through the Korea Food and Drug Administration and Food Raw Materials Search (2007) .The sensory characteristics are 100ml after removing the steering agent after heating for 6 hours (93 ± 3 ℃) by adding water (3500g) to the raw material (50g). A concentrated sample was provided and obtained through the sensory description through the sensory panel (3 persons).
율무의 경우 제품의 탁도를 증가시키므로 본 발명의 양파농축액에 첨가되는 천연조향제로 적합하지 않으며, 감초, 당귀, 갈근, 천궁, 소엽, 다시마는 본 발명에 첨가되는 천연조향제로 적합하다.In the case of yulmu increase the turbidity of the product is not suitable as a natural flavoring agent added to the onion concentrate of the present invention, licorice, Angelica, brown root, celery, lobule, kelp is suitable as a natural flavoring agent added to the present invention.
1-2. 양파농축액 제조1-2. Onion concentrate preparation
양파는 품질기준인 대(大) 이상(높이 8.2~8.4cm, 직경 8.7~8.8cm로 구형지수가 94~98%로 원형에 가까움)인 창녕명품양파를 선별하였다. 선별된 양파 5kg를 4회 수세하여 이물질을 제거한 후 세절하고, 세절된 양파는 강목에 담아 물 3.15kg과 함께 이중증기솥에서 96~99℃에서 6시간 처리하였다. 이때 선별된 천연조향제를 함께 강목에 담아 자숙하였다. 양파 자숙액을 120 메시(mesh) 여과망에 여과시켰다. 여과되지 않은 잔사는 체반(스텐)에 8~10시간 방치한 후 여과시켜 여과액과 양파박으로 분리하였다. 여과액들을 집하하여 15 브릭스(oBrix)의 양파농축액으로 이중증기솥(96~99℃)에서 농축하여 제조하였다.Onion was selected from Changnyeong luxury onions with quality criteria above (large) 8.2 ~ 8.4cm in height, 8.7 ~ 8.8cm in diameter and spherical index of 94 ~ 98%. After washing the selected onion 5kg 4 times to remove foreign substances, and then cut, the sliced onion was placed in the wood and treated with 3.15kg of water in a double steamer at 96-99 ℃ for 6 hours. At this time, the selected natural flavoring agent was put together in the wood. Onion cooked liquor was filtered through a 120 mesh filter network. The unfiltered residue was left for 8-10 hours in a placenta (sten) and filtered to separate the filtrate and onion foil. Filtrates were collected and concentrated in a double steamer (96-99 ° C) with 15 Brix ( o Brix) onion concentrate.
제조된 양파농축액은 분말제조가 가능하며, 분말제조를 위한 분무건조시 시료의 열용해성을 고려하여, 부형제는 말토덱스트린 이나 덱스트린 (포도당 당량, dextrose equivalent : 8~25)을 사용하여 분말제품을 개발하였다. The prepared onion concentrate can be manufactured in powder.In consideration of the thermal solubility of the sample during spray drying for the manufacture of powder, the excipient develops a powder product using maltodextrin or dextrin (glucose equivalent, 8 ~ 25). It was.
1-3. 양파농축농도에 따른 선호도 조사1-3. Investigation of preference according to onion concentration
양파농축액의 4가지 농도(12, 15, 18, 21 。브릭스)에 대한 선호도 순위검사를 색, 냄새, 맛, 점성 등을 고려한 전반적인 기호도 측면에서 실시하였다. 실험에 사용된 양파농축액은 본 발명의 제조방법에 의해 제조되었다. 관능검사는 창원대학교 교직원(35세 이상) 20명을 대상으로 오후 3~4시 사이에 실시하였으며, 한번에 4가지 검사 시료를 모두 제시하고 가장 좋아하는 것(1위)부터 좋아하지 않는 것(4위) 순으로 순위를 정하도록 하였다. 시료는 양파농축액을 패널요원이 잘 관찰할 수 있도록 투명한 플라스틱 컵에 30 mL씩 담아 제공하였으며 하나의 시료를 먹고 나면 반드시 미지근한 물과 크래커로 입안을 가신 뒤 다음 시료를 평가하도록 하였다. 평가결과는 표 2와 같다.Onion concentrate were 4 concentrations (12, 15, 18, 21 Brix) a preference rank test for color, odor, overall acceptability side considering the taste, viscosity and the like. Onion concentrate used in the experiment was prepared by the production method of the present invention. The sensory test was conducted between 3 and 4 pm at Changwon University's 20-year-old faculty (over 35 years old) .The four test samples were presented at the same time and the favorite (first place) was not preferred (fourth place). In order to rank). Samples were provided with 30 mL of onion concentrate in transparent plastic cups for panelists to observe well. After eating one sample, be sure to go through the mouth with lukewarm water and crackers and evaluate the next sample. The evaluation results are shown in Table 2.
상기 표 2에서 괄호 안의 수는 순위를 나타내며 패널이 검사한 결과는 순위법 유의성 검정표(5%)를 참조하여 처리수 4와 반복수 20에 해당하는 최소 및 최대 비유의적 순위 합계는 5% 유의수준에서 39-61이다. 따라서 순위합이 39-61 사이 값은 유의하게 상이하지 않았다(n=20, p<0.05).In Table 2, the numbers in parentheses indicate the rankings, and the panel inspection results refer to the ranking method significance test table (5%), and the sum of the minimum and maximum non-significant rankings corresponding to the number of
양파농축정도에 따른 선호도 검사 결과 15 0Brix의 양파농축액이 가장 높은 기호도를 나타내었다.As a result of the preference test according to the degree of onion concentration, onion concentrate of 15 0 Brix showed the highest acceptability.
1-4. 천연조향제 첨가 비율 최적화 1-4. Optimizing Natural Sterilization Rate
선호도순위검사에서 1순위로 선정된 15 brix 양파농축액의 강한 양파 냄새로 인한 문제점을 해결하기 위하여 보향제로서 천연조향제를 첨가하여 이취를 상쇄시키고자 하였다. 따라서 6종의 천연조향제가 동일비율로 조합된 천연조향제 혼합물을 4가지 농도(양파 중량 대비 0.25, 0.50, 0.75, 1.00(%))로 첨가하여 제조한 15 brix 양파농축액을 훈련된 패널요원 14명을 대상으로 특성강도조사를 실시하였다. 이때 사용된 관능특성으로는 양파향, 천연조향제냄새, 양파맛, 단맛, 천연조향제맛, 쓴맛이었으며 7점 척도(1: 없음, 4: 중간, 7: 강함)를 사용하여 평가하였다. 평가결과는 표 3과 같다. In order to solve the problem caused by the strong onion smell of 15 brix onion concentrate, which was selected as the first priority in the preference ranking test, we tried to offset the odor by adding natural flavor as a supplement. Therefore, 15 brix onion concentrate prepared by adding four natural flavor mixtures (0.25, 0.50, 0.75, 1.00 (%) to onion weight) with six natural flavors in equal proportions were trained panelists. A characteristic strength survey was conducted for all persons. The sensory characteristics used were onion flavor, natural flavor, natural flavor, sweet taste, natural flavor, bitter taste, and were evaluated using a 7-point scale (1: none, 4: medium, 7: strong). The evaluation results are shown in Table 3.
실험결과 천연조향제 혼합물의 농도가 증가할수록 양파의 향과 맛은 감소하고 천연조향제 냄새와 맛이 증가하는 경향을 보였다. 단맛과 쓴맛은 첨가농도에 따른 유의적인 차이는 없었으나 쓴맛은 천연조향제 혼합물의 농도가 증가할수록 다소 강해지는 경향을 보였다. 천연조향제 혼합물의 첨가 농도가 0.50 (%)를 초과한 경우 양파의 향과 맛이 감소하면서 천연조향제의 향과 맛의 인식정도가 유의적으로 높아졌다. 따라서 양파의 향과 맛이 천연조향제와 잘 어울려 양파의 이취가 다소 감소되는 천연조향제 혼합물 0.5 (%) 이하 수준이 양파농축액 제조에 적합한 것으로 나타났다.Experimental results showed that as the concentration of the natural flavor mixture increased, the flavor and taste of onion decreased and the smell and taste of the natural flavor increased. The sweet and bitter tastes were not significantly different depending on the concentration of the bitter, but the bitter taste tended to be stronger as the concentration of the natural flavor mixture increased. When the concentration of the natural flavor mixture exceeded 0.50 (%), the flavor and taste of the natural flavor increased significantly as onion flavor and taste decreased. Therefore, the flavor and taste of onions matched well with natural flavoring agents, and the level of natural flavor mixtures of 0.5 (%), which reduced the off-flavor of onions, was found to be suitable for producing onion concentrate.
따라서 천연조향제 혼합물을 전혀 첨가하지 않은 대조군과 0.25 (%), 0.50 (%)를 첨가한 15 브릭스(oBrix) 양파농축액에 대하여 소비자 검사를 실시하였다. 관능검사는 창원대학교 교직원(35세 이상) 40명을 대상으로 실시하였으며, 시료 준비 및 평가방법은 양파농축액 적정 농도 결정시와 동일하게 선호도 순위검사를 수행하였다. Therefore, a consumer test was carried out with respect to the control group and 0.25 is not added at all to natural steering the mixture (%), a 15 Brix (Brix o) was added to 0.50% onion concentrate. The sensory test was performed on 40 faculty members (over 35 years old) of Changwon National University. The method of sample preparation and evaluation was carried out in the same way as in the case of determining the optimal concentration of onion concentrate.
상기 표 4의 괄호 안의 수는 순위를 나타내며 패널이 검사한 결과는 순위법 유의성 검정표(5%)를 참조하여 처리수 4와 반복수 40에 해당하는 최소 및 최대 비유의적 순위 합계는 5% 유의수준에서 69-91이다. 따라서 순위합이 69-91 사이 값은 유의하게 상이하지 않았다(n=40, p<0.05).The numbers in parentheses in Table 4 represent the rankings, and the results examined by the panel refer to the ranking method significance test table (5%), and the sum of the minimum and maximum non-significant rankings corresponding to the number of
실험결과는 색, 향, 맛 등을 고려한 전반적 기호도에서 천연조향제 혼합물 0.50(%)는 전반적인 기호도 순위가 1순위로 가장 선호하는 것으로 나타났으며 대조군와 천연조향제 혼합물 0.25(%)는 동일 순위(2위)를 차지하였다. 결과적으로 양파농축액에 천연조향제 혼합물 0.50(%)를 첨가함으로써 전반적으로 선호도가 향상됨을 알 수 있었다.The experimental results showed that 0.50 (%) of natural flavor mixtures were the most preferred in the overall preference ranking in consideration of color, aroma, and taste, and 0.25 (%) of control and natural flavor mixtures were the same ( Second place). As a result, the preference was improved by adding 0.50 (%) of natural flavor mixture to onion concentrate.
<< 실험예Experimental Example 1 > 양파농축액의 성분분석 1> Component Analysis of Onion Concentrate
1-1. 퀘세틴 함량 측정1-1. Quercetin Content Determination
건강기능성식품의 원료의 표준화를 검증을 위해 양파농축액을 3회 제조하여 각 제조공정에 따라 지표성분인 퀘세틴 함량을 측정하였다.In order to verify the standardization of raw materials of health functional foods, onion concentrate was prepared three times, and the content of quercetin as an indicator component was measured according to each manufacturing process.
퀘세틴의 분석 방법은 시료 1g에 40mL의 60% 에탄올과 6M 염산 5mL를 첨가한 후 95℃ 수욕상에서 2시간 동안 환류 냉각하였다. 환류 냉각시킨 용액은 50mL로 되도록 정용 한 후 0.45um filter로 여과하여 고성능액체크로마토그래피(Hewlett Packard model 1100 series, USA)로 분석하였다. 이때 컬럼은 HP ZOBAX 컬럼 (XDB-C18, Hewlett Packard, USA)를 사용하였다. 이동상 용매는 아세토니트릴(acetonitrile), 5% 아세트산(acetic acid)를 사용하였고 유속은 1mL/min, 파장은 370nm에서 분석하였다. 시료 중 퀘세틴의 함량은 표품과의 머무름시간을 비교하여 동정하였고 검량선을 이용한 피크의 면적으로 퀘세틴을 정량 하였다.In the method for analyzing quercetin, 40 mL of 60% ethanol and 5 mL of 6M hydrochloric acid were added to 1 g of the sample, followed by cooling under reflux for 2 hours in a 95 ° C water bath. The reflux cooled solution was applied to 50 mL, filtered through a 0.45 um filter, and analyzed by high performance liquid chromatography (Hewlett Packard model 1100 series, USA). Where the column is an HP ZOBAX column (XDB-C18, Hewlett Packard, USA) was used. Acetone nitrile (acetonitrile), 5% acetic acid (acetic acid) was used as the mobile phase solvent, and the flow rate was analyzed at 1 mL / min and the wavelength at 370 nm. The content of quercetin in the sample was determined by comparing the retention time with the standard and the quercetin was quantified by the area of the peak using the calibration curve.
3회의 실험을 수행한 결과 원료인 양파는 15.28~17.63 mg/100g의 함량을 나타내었다. 자숙 및 여과과정 후 퀘세틴은 다소 감소하여 9.42~12.66mg/100g을 가졌고 농축 과정을 통하여 17.22~24.52mg/100g으로 증가하였다. 따라서 퀘세틴은 제조공정에 변화에 따라 일정한 함량을 안정적 유지하여 생리적 활성 지표성분 물질에 적합함을 보였다.As a result of three experiments, onion, a raw material, showed a content of 15.28 ~ 17.63 mg / 100g. After ripening and filtration, quercetin decreased slightly from 9.42 to 12.66 mg / 100 g and increased to 17.22 to 24.52 mg / 100 g through concentration. Therefore, quercetin has been shown to be suitable for the physiologically active indicator component by maintaining a constant content in accordance with changes in the manufacturing process.
1-2. 일반성분 측정1-2. General ingredient measurement
양파농축액의 일반성분은 미국공인분석화학회(Association of official analytical chemists, AOAC)법에 따라 수분은 상압 가열건조법, 조회분은 직접 회분법, 조지방은 soxhlet법, 조단백질은 semi-micro kjeldahl법, 식이섬유는 식품공전에 따라 분석한 결과 수분 86.0~86.1%, 조회분 0.7~0.8%, 조지방 0.6~1.6%, 조단백질 1.2~1.6%, 식이섬유 0.98~1.15%로 나타났다. The general composition of onion concentrates is obtained by atmospheric pressure drying method, moisture content by direct ash method, crude ash by soxhlet method, crude protein by semi-micro kjeldahl method, and diet according to the Association of official analytical chemists (AOAC) method. Fibers were analyzed to be 86.0 ~ 86.1%, crude ash 0.7 ~ 0.8%, crude fat 0.6 ~ 1.6%, crude protein 1.2 ~ 1.6%, dietary fiber 0.98 ~ 1.15%.
1-3. 페놀화합물의 분석1-3. Analysis of Phenolic Compounds
산화물질의 대표적인 총 페놀화합물의 분석은 singleton 등의 방법을 변형한 Liu 등의 방법으로 증류수 0.5mL에 시료 125μL를 증류수 0.5 mL에 혼합한 후 폴린-시오칼테오 용액(Folin-Ciocalteu reagent) 125μL를 첨가하여 6분간 방치하였다. 이 혼합물에 7% 소디움 카보네이트(sodium carbonate) 1.25 mL 넣고 최종 부피가 3 mL이 되도록 증류수로 조절 한 후에 90분간 실온에서 방치하여 흡광도기로 760 nm에서 흡광도를 측정하였다. 이때 총 폴리페놀 화합물은 갈릭산(gallic acid)을 이용하여 작성한 표준검량선으로 부터 함량을 구하였다.The analysis of representative total phenolic compounds of oxidizing materials was carried out by Liu et al., Which modified the method of singleton etc., and mixed 125 μL of 0.5 mL of distilled water with 0.5 mL of distilled water and then added 125 μL of Folin-Ciocalteu reagent. And left for 6 minutes. 1.25 mL of 7% sodium carbonate was added to the mixture, and the final volume was adjusted to distilled water so that the final volume was 3 mL. The mixture was left at room temperature for 90 minutes and absorbance was measured at 760 nm with an absorbance. At this time, the total polyphenol compound was determined from the standard calibration curve prepared using gallic acid.
양파농축액의 폴리페놀화합물의 함량은 10.68~13.93 mg/mL 범위로 저장기간에 따라 유지하였다. The content of polyphenol compound in onion concentrate was maintained in the range of 10.68 ~ 13.93 mg / mL depending on the storage period.
1-4. 플라보노이드의 분석1-4. Analysis of Flavonoids
총 플라보노이드의 분석은 Liu 등의 방법과 Jia 등의 방법을 변형하여 분석하였다. 즉, 0.25mL의 각 시료를 증류수 1.25 mL 증류수에 희석시킨 후 5% 소디움니트리트(NaNO2)용액 0.075 mL 가하여 5분동안 방치하였다. 이 혼합액에 10% 알루미늄 클로라이드(AlCl36H2O) 0.15 mL 넣고 6분 후에 1M 수산화나트륨(NaOH) 0.5 mL첨가하여 최종 부피가 3 mL이 되도록 증류수 (0.775 mL)로 조절한 다음 흡광도기를 사용 하여 510 nm에서 흡광도를 측정하였다. 이때 총 플라보노이드 함량은 카테킨((+)-catechin)을 이용하여 작성한 표준검량선으로 부터 함량을 구하였다.Total flavonoids were analyzed by modifying Liu et al. And Jia et al. That is, 0.25 mL of each sample was diluted with 1.25 mL of distilled water, and then 0.075 mL of 5% sodium nitrile (NaNO 2 ) solution was added thereto and left for 5 minutes. 10% aluminum chloride (AlCl 3 6H 2 O) in this mixture After 6 minutes, 0.15 mL of 1M sodium hydroxide (NaOH) was added thereto, and the final volume was adjusted to distilled water (0.775 mL) so that the final volume was 3 mL. The absorbance was measured at 510 nm using an absorber. The total flavonoid content was calculated from the standard calibration curve prepared using catechin ((+)-catechin).
저장 기간에 따른 양파농축액의 총 플라보노이드 함량은 양파농축액 A와 B 각각 161.73~168.40 mg/100mL, 148.02~162.11 mg/100mL의 함량을 유지하였고 양파농축액은 다소 낮은 함량인 115.83~130.88 mg/100mL 범위로 유지하였다.The total flavonoid content of onion concentrates according to the storage period was 161.73 ~ 168.40 mg / 100mL and 148.02 ~ 162.11 mg / 100mL, respectively. Onion concentrates ranged from 115.83 ~ 130.88 mg / 100mL, which is somewhat lower. Maintained.
1-5. 포화지방 및 트랜스지방 함량 분석1-5. Saturated and trans fat content analysis
포화지방 및 트랜스 지방은 계명대학교 전통미생물자원연구센터(식품의약품안전청 식품위생검사기관)에 의뢰하여 식품공전에 따라 분석하였다. Saturated and trans fats were commissioned by Keimyung University Traditional Microbiological Resources Research Center (Food Hygiene Inspection Agency, Korea Food and Drug Administration) and analyzed according to the Food Code.
즉 시료에서 지방을 추출한 후 시험관에 약 25mg의 시료를 주입하고, 0.5N 메탄올성 수산화나륨(methanolic NaOH)를 1.5mL를 혼합한 후 100℃ 가열 반응시킨다음, 반응이 끝난 시료를 30~40℃에서 냉각 시킨 후 보론 트리프로이드 14% 메탄올 용액 (boron trifluoride methanol 14% solution)시약 2mL 첨가하여 100℃에서 30분간 반응시켰다. 반응물을 40℃로 냉각하여 이소옥탄(iso-octane) 2mL를 첨가한 후, 격렬하게 혼합한 다음 상층액을 취하여 소디움설페이트(sodium sulfate)를 이용해 탈수 후 가스크로마토그래피(GC)에 주입하여 정량 분석하였다. 이때 사용한 칼럼은 SP-2560(100m × 0.25mm × 0.20um)를 사용하였다. 오븐조건은 130℃에서 5분간 유지하고 2℃/min속도로 230℃까지 온도를 올린 후 15분간 유지하였다. 유속은 1.2mL/min으로 하였다. 포화지방 및 트랜스지방의 동정 및 정량은 표준 화합물과 시료의 가스크로마토그래피의 머무름 시간이 일치하는 피크(peak)와 동일한 물질로 하여 정량 분석하였다. 상기 분석 결과, 일반적인 영양성분인 포화지방, 트랜스지방 및 콜레스테롤이 양파농축액에는 검출되지 않았다.That is, after extracting fat from the sample, about 25mg of sample is injected into a test tube, 1.5N of 0.5N methanolic sodium hydroxide (methanolic NaOH) is mixed, and then reacted by heating at 100 ° C. After cooling at 2 ml of boron trifluoride methanol 14% solution was added and the reaction was carried out at 100 ° C. for 30 minutes. The reaction was cooled to 40 ° C., 2 mL of isooctane was added thereto, mixed vigorously, the supernatant was taken, dehydrated using sodium sulfate, and then injected into gas chromatography (GC) for quantitative analysis. . SP-2560 (100 m x 0.25 mm x 0.20 um) was used for the column. Oven conditions were maintained for 5 minutes at 130 ℃ and the temperature was raised to 230 ℃ at a rate of 2 ℃ / min and maintained for 15 minutes. The flow rate was 1.2 mL / min. Identification and quantification of saturated fat and trans fat were quantitatively analyzed with the same material as the peak (peak) in which the retention time of the standard compound and the sample was matched. As a result of the above analysis, saturated fat, trans fat and cholesterol, which are common nutrients, were not detected in onion concentrate.
1-6. 무기질 원소 분석1-6. Inorganic Element Analysis
일반무기질원소 칼슘, 철, 칼륨, 인, 나트륨 및 아연 총 6종을 선정하여 분석하였다. 시료 1g을 채취 하여 전기도가니(600℃, 3시간)에서 회화를 하였다. 회화 후 시료에 질산과 염산 혼합용액 (질산:염산 = 1:3) 10mL 를 첨가한 후 180℃에서 20분간 가열 한 후 질산과 염산 혼합용액 (질산:염산 = 1:3) 5mL 넣고 180℃에서 20분간 재가열 반응을 시켰다. 반응물은 25mL 정용플라스크로로 옮겨 ICP로 분석하였다.Six kinds of general inorganic elements calcium, iron, potassium, phosphorus, sodium and zinc were selected and analyzed. 1 g of the sample was taken and incinerated in an electric crucible (600 ° C., 3 hours). After incubation, 10 mL of a mixture of nitric acid and hydrochloric acid (nitric acid: hydrochloric acid = 1: 3) was added to the sample, followed by heating at 180 ° C. for 20 minutes, and then 5 mL of mixed nitric acid and hydrochloric acid solution (nitric acid: hydrochloric acid = 1: 3) were added at 180 ° C. Reheating reaction was carried out for 20 minutes. The reaction was transferred to a 25 mL flask and analyzed by ICP.
세포내액의 주된 양이온으로 산, 염기의 평형 유지 및 근육의 수축과 이완작용에 주된 역할을 하는 칼륨은 1517.21~2018.19 ppm으로 가장 많은 함량을 차지하였고 인, 칼슘 및 나트륨이 각각 340.12~395.06 ppm 232.95~254.50 ppm, 155.96~201.50 ppm 순으로 양파농축액 시료 간에 다소 함량의 차이는 있었으나 구성비는 유사한 범위를 가졌다 (표 9).Potassium, the major cation in intracellular fluids, plays an important role in the equilibrium of acids and bases, and in the contraction and relaxation of muscles, with 1517.21 ~ 2018.19 ppm of potassium, 340.12 ~ 395.06 ppm 232.95 ~, respectively. 254.50 ppm, 155.96 ~ 201.50 ppm, there was a slight difference in content between onion concentrate samples, but the composition ratio was similar range (Table 9).
1-7. 향기 성분 분석1-7. Fragrance component analysis
양파농축액의 휘발성 향기성분분석은 Kim의 방법을 변형하여 분석하였다. Volatile Flavor Components of Onion Concentrates were analyzed by modifying Kim's method.
즉 고상미량추출장치(solid phase micro-extraction device, SPME장치)를 사용하였으며, 흡착용 파이버는 폴리디메틸실록산/디비닐벤진(polydimethylsiloxane/ divinylbenzene, PDMS/DVB) 파이버(65um coating thickness)를 사용하였다. 시료 30g을 헤드스페이스 유리병 (headspace glass vial)에 넣고 알루미늄 크림프 실(alumimum crimp seal, 20mm, open center)과 폴리테트라프로개에틸렌/실리콘 셉텀(polytetrafluoroethylene/sillicone septum, 60 mils)으로 밀봉한 후 40℃에서 50분간 파이버를 유리병내에 노출시켜 휘발성 화합물을 흡착시켰다.That is, a solid phase micro-extraction device (SPME device) was used, and adsorption fibers were made of polydimethylsiloxane / divinylbenzene (PDMS / DVB) fiber (65um coating thickness). 30 g of sample was placed in a headspace glass vial and sealed with an aluminum crimp seal (20 mm, open center) and polytetrafluoroethylene / sillicone septum (60 mils). The fibers were exposed in a glass jar at 50 ° C. for adsorbing volatile compounds.
휘발성 성분은 HP 6890 GC/5973 mass selective detector (MSD, Hewlett-packdard Co., Palo Alto, CA, USA)로 분석하였다. 분석용 컬럼은 DB-WAXETR capillary column (60m×0.25mm I.d×0.25um film thickness, J&W Sci,. USA)를 사용하였다. 자세한 GC/MSD분석조건은 Cha 등의 방법에 따랐다. 각 휘발성 화합물의 동정은 retention index (RI) 및 standard MS library data (Wiley 275K, Hewlett-Pakard Co., USA)에 의하였으며, 휘발성 화합물의 함량은 내부표준물질을 이용하여 상대적 함량으로 환산하였다 (factor=1, ng/g).Volatile components were analyzed by HP 6890 GC / 5973 mass selective detector (MSD, Hewlett-packdard Co., Palo Alto, CA, USA). DB-WAXETR capillary column (60m × 0.25mm I.d × 0.25um film thickness, J & W Sci, USA) was used for the analytical column. Detailed GC / MSD analysis conditions were followed by Cha et al. The identification of each volatile compound was based on retention index (RI) and standard MS library data (Wiley 275K, Hewlett-Pakard Co., USA), and the content of volatile compounds was converted to relative content using an internal standard. = 1, ng / g).
그 결과, 양파농축액의 향기성분으로서, 함황화합물류 (9종), 알데하이드류 (6종), 방향족화합물류 (2종), 에스테르 (1종), 알콜류 (1종), 퓨란류 (1종), 케톤류 (1종) 및 기타화합물류 (2종)으로 총 23종의 화합물이 검출되었다. As a result, as a fragrance component of onion concentrate, sulfur-containing compounds (9 types), aldehydes (6 types), aromatic compounds (2 types), esters (1 type), alcohols (1 type), furan (1 type) ), Ketones (1 type) and other compounds (2 types) were detected in total 23 kinds of compounds.
상기 함황화합물 중 양배추향의 디메칠 디설파이드(dimethyl disulfide)와 고기향의 디메칠 트리설파이드(dimethyl trisulfide)가 대부분의 함량을 차지하였고 특히 디메칠 디설파이드(dimethyl disulfide)와 메틸 프로필 디설파이드(methyl propyl disulfide)가 저장기간에 함량이 증가하는 경향을 보여 양파농축액의 향미에 중요한 향기성분으로 사료된다. 또한, 알데하이드류 중 육즙향의 푸푸랄(furfural)과 쓴 아몬드향의 5-메틸-2-푸푸랄(5-methyl-2-furfural) 의 함량이 높았다. 저장기간에 따라 푸푸랄(furfural)의 함량은 증가하였으나 초코렛향의 3-메틸부탄알(3-methylbutanal)의 함량은 감소하였다. 방향족 화합물인 4-알릴메토시벤진(4-ally methoxybenzene)은 저장기간에 따라 함량이 증가한 반면 파인애플향의 에틸 에세테이트(ethyl acetate)와 클로로포름(chloroform)의 함량은 감소하였다 (표 10). Among the sulfur compounds, cabbage dimethyl disulfide and meat flavor dimethyl trisulfide occupy most of the contents, in particular dimethyl disulfide and methyl propyl disulfide. It is considered to be an important fragrance ingredient in flavor of onion concentrate as it shows a tendency to increase during storage period. In addition, the content of juicy furfural (furfural) and bitter almond flavor 5-methyl-2-furfural (5-methyl-2-furfural) in the aldehydes was high. Furfural content increased with storage period, but 3-methylbutanal content of chocolate decreased. The aromatic compound 4-allymethoxybenzine (4-ally methoxybenzene) increased with storage period, while the pineapple flavored ethyl acetate and chloroform decreased (Table 10).
항산화 효과가 있는 것으로 알려진 함황 화합물은 일반적으로 티오펜(thiophene) 유도체(2,4-dimethyl thiophene 및 2.5-dimethyl thiophene)이며, 본 실험에서 동정된 3-메틸-티오펜(3-Methyl thiophene)과 2,4-디메틸티오펜(2,4-Dimethyl thiophene)이 저장 기간 동안 유지되는 경향을 보였다. 그러므로 휘발성 함황 화합물에서 기대될 수 있는 항산화력이 제품의 저장기간에 따라 안정적으로 유지가 될 것이라고 기대된다.Sulfur-containing compounds known to have antioxidant effects are generally thiophene derivatives (2,4-dimethyl thiophene and 2.5-dimethyl thiophene), and 3-methyl-thiophene (3-Methyl thiophene) identified in this experiment. 2,4-dimethylthiophene (2,4-dimethyl thiophene) tended to be maintained during the storage period. Therefore, it is expected that the antioxidant power that can be expected from volatile sulfur compounds will remain stable over the storage period of the product.
< < 실험예Experimental Example 2> 저장기간에 따른 저장안정성 시험 2> Storage stability test according to storage period
2-1. 양파농축액의 원재료의 안전성 검증을 위한 잔류농약분석 2-1. Residual Pesticide Analysis for Verification of Raw Material of Onion Concentrate
양파농축액의 잔류농약 디디티(DDT), 디엘드린(Dieldrin), 알드린(Aldrin), 엔드린(Endrin), 메타락실(Metalaxyl), 아조시스트로빈(Azoxystrobin), 비에이치시(BHC) 7종을 분석하였다. Residual Pesticides (DDT), Dieldrin, Aldrin, Endrin, Metaaxyl, Azoxystrobin, BHC of Onion Concentrates were analyzed. .
분석은 계명대학교 전통미생물자원연구센터(식품의약품안전청 식품위생검사기관)에서 수행되었으며 분석방법은 식품공전에 따라 분석을 행하였다. 즉, 균질화된 시료 50g에 아세토니트릴(acetonitrile) 100ml와 혼합한 후 감압 여과하였다. 여과물은 염화나트륨 15g을 혼합한 후 아세토니트릴 층을 분리하여 감압 농축한다. 농축물에 20% 아세톤 함유 헥산 2mL에 녹여 준비된 셉-팍(sep-pak)카트리지에 적재한 후 농축 용출액 2mL를 시험관에 받았다. 이때 20% 아세톤/헥산 2.5mL로 씻어 시험관으로 유출된 액을 농축하였다. 농축액은 20% 아세톤/헥산 2mL로 녹여 기체크로마토그래피/전자포획검출법으로 분석하였다. 상기 분석에 사용된 컬럼은 ZB-1 (60m×0.25mm×0.32um)이다. 오븐 온도는 120℃에서 2분간 유지하였다가 10℃/분 속도로 200℃까지 올린 후 2분간 유지시키고 후 5℃/분 속도로 250℃까지 상승시켜 2분간 유지하였다. 다시 10℃/분 속도로 290℃까지 올려 2분간 유지하여 분석을 하였다. The analysis was performed at Keimyung University's Traditional Microbial Resources Research Center (Food Hygiene Inspection Agency, Korea Food and Drug Administration). That is, 50 g of the homogenized sample was mixed with 100 ml of acetonitrile and filtered under reduced pressure. The filtrate is concentrated under reduced pressure by mixing 15 g of sodium chloride, separating the acetonitrile layer. The concentrate was dissolved in 2 mL of 20% acetone-containing hexane and loaded into a prepared sep-pak cartridge, and 2 mL of the concentrated eluate was received in a test tube. At this time, the solution was washed with 2.5 mL of 20% acetone / hexane to concentrate the liquid spilled into the test tube. The concentrate was dissolved in 2 mL of 20% acetone / hexane and analyzed by gas chromatography / electron capture detection. The column used for this analysis is ZB-1 (60 m × 0.25 mm × 0.32um). The oven temperature was maintained at 120 ° C. for 2 minutes, raised to 200 ° C. at 10 ° C./minute, and maintained for 2 minutes, and then maintained at 250 ° C. at 5 ° C./min for 2 minutes. Again, the analysis was carried out by raising the temperature to 290 ° C. at 10 ° C./min for 2 minutes.
분석결과 디디티(DDT), 디엘드린(Dieldrin), 알드린(Aldrin), 엔드린(Endrin), 메타락실(Metalaxyl), 아조시스트로빈(Azoxystrobin), 비에이치시(BHC) 7종은 양파농축액에서 검출되지 않았다.As a result, 7 types of DDD, Dieldrin, Aldrin, Endrin, Metaaxyl, Azoxystrobin and BHC were not detected in onion concentrate. Did.
2-2. 양파농축액의 중금속 함량 측정 2-2. Determination of Heavy Metals in Onion Concentrate
원재료 및 가공공정 중 유해물질의 혼입 검증을 위한 중금속 함량을 측정하였다. 분석은 계명대학교 전통미생물자원연구센터(식품의약품안전청 식품위생검사기관)에서 수행되었으며, 양파농축액에서 카드뮴, 납, 수은 및 비소 4종의 중금속을 측정하였다. 분석방법은 시료를 취하여 탄화시킨 후 550~600℃의 온도에서 여러시간 가열하여 백색~회백색의 회분이 얻어질 때까지 회화한다. 이 회분을 방냉후 주의하여 물로 적신 후 염산 10mL를 가해 수욕상에서 완전 증발건고시킨다. 이런 건고물에 염산용액 10mL를 가해 수분 가열 후 100mL 메스플라스크에 여과한다. 불용물은 회화용기에 옮겨 건고한 후 다시 회화한다. 이 회분을 물로 적시어 염산용액 2mL를 가해 물 5mL로 희석한 후 수욕상에서 가온하고 여과한 액을 앞의 100mL 메스플라스크에 채워 물을 가해 100mL로 한 시험용액을 ICP로 분석하였다.Heavy metal content was measured to verify the incorporation of hazardous materials in raw materials and processing. The analysis was performed at Keimyung University's Traditional Microbiological Resources Research Center (Food Hygiene Testing Institution, Korea Food and Drug Administration) and four heavy metals were measured in onion concentrate. The analytical method takes a sample, carbonizes it, and heats it at a temperature of 550-600 ° C. for several hours to incubate until white to gray ash is obtained. After cooling the ash, carefully wet it with water, add 10 mL of hydrochloric acid, and evaporate to dryness in a water bath. 10 mL of hydrochloric acid solution is added to the dried material, and the resultant is heated in water and filtered through a 100 mL volumetric flask. Insoluble materials are transferred to painting containers, dried, and then repainted. The ash was soaked with water, 2 mL of hydrochloric acid solution was added, diluted with 5 mL of water, and then heated in a water bath. The filtered solution was filled in a 100 mL volumetric flask and water was added to analyze the test solution.
양파농축액에서 카드뮴, 납, 수은 및 비소 4종의 중금속 측정한 결과는 표 13에 제시하였다. 분석결과 과잉으로 섭취하였을 때 단백뇨, 위장장애 및 골격의 무기질 감소증과 장애를 일으키는 이따이-이따이 (itai-itai)병을 초래하는 카드뮴, hemoglobin 결핍으로 인한 빈혈, 산통, 뇌 손상마비를 가져오는 납 및 arsenic-thyroid antagonism을 나타내는 비소는 양파농축액에서 검출되지 않았으나 수은는 0.003~0.009mg/kg 범위로 측정되었다. 우리나라의 경우 농산 가공품에 대한 수은의 기준은 설정되어 있지 않으나 본 실험의 범위는 당근, 토마토, 양파에서 발견되는 수은 함량 0.001 ppm의 보고와 유사하므로 양파농축액의 수은의 함량은 자연에 존재하는 안전한 수준의 함량으로 검출된 것으로 사료된다. Table 13 shows the measurement results of four heavy metals of cadmium, lead, mercury, and arsenic in onion concentrates. Analysis shows that excessive intake leads to proteinuria, gastrointestinal disorders, and lead-induced anemia, colic, cerebral injuries due to deficiency of cadmium, hemoglobin deficiency, which causes itia-itai disease and disorders. Arsenic, which represents arsenic-thyroid antagonism, was not detected in onion concentrates, but mercury was measured in the range of 0.003 to 0.009 mg / kg. In Korea, mercury standards for agricultural products are not established, but the scope of this experiment is similar to the report of 0.001 ppm of mercury found in carrots, tomatoes, and onions. Therefore, the mercury content of onion concentrates is safe in nature. It is thought to be detected by the content of.
2-3. 양파농축액의 미생물학적 안정성 평가2-3. Microbiological Stability Evaluation of Onion Concentrate
유통기간 중 양파농축액의 안정성 검증을 위하여 제조된 양파농축액을 30℃ 저장고에 보관한 후 미생물학적 안정성을 측정하였다.Microbiological stability was measured after storing the onion concentrate prepared in order to verify the stability of the onion concentrate during the shelf life in 30 ℃ storage.
일반 생균수는 시료 1mL를 무균적으로 취하여 0.85% 생리식염수 9mL에 희석하는 10진 희석법으로 시료를 준비한 다음 희석액 1mL 표준한천배지에 부어 생균수를 측정하는 주입평판법에 따라 실험을 행하였다.The general viable count was prepared by a decimal dilution method in which 1 mL of the sample was aseptically taken and diluted in 9 mL of 0.85% physiological saline, and then the sample was poured into 1 mL standard agar medium to measure the viable cell count.
저장기간에 따라 양파농축액 일반세균수를 측정한 결과 저장 150일 동안 10 CFU/mL 미만으로 측정되어 미생물학적 안정성을 보였다. According to the storage period, the general bacterial count of onion concentrate was measured as less than 10 CFU / mL during storage for 150 days, showing microbiological stability.
대장균군의 유무를 검사하기 위하여 정성시험인 유당배지법에 따라 실험을 하였다. 즉 유당배지를 가한 발효관에 시료를 넣어 35℃에서 48시간 동안 배양하여 발생 여부를 판정하였다.In order to check the presence of E. coli group, the experiment was conducted according to the lactose medium method, a qualitative test. That is, the samples were placed in a fermentation tube to which lactose medium was added, and cultured at 35 ° C. for 48 hours to determine whether they occurred.
저장기간에 따라 양파농축액에서 대장균군이 검출되지 않아 위생학적 안정성을 보였다. According to the storage period, E. coli group was not detected in onion concentrate, which showed hygienic stability.
2-4. 양파농축액의 저장기간 중 품질 변화 측정2-4. Measurement of quality change during storage period of onion concentrate
저장기간 중 pH와 색도의 측정 및 차이식별검사를 통한 품질변화를 측정하였다.During the storage period, quality changes were measured by measuring pH and chromaticity and identifying differences.
pH 측정은 시료를 원심분리(4℃, 16,000×g, 20 min) 한 후 상등액을 pH meter(Mettler Delta 320, Mettler-Toledo Ltd., England)를 사용하여 측정하였다. 색도 측정은 색차계(CM-3500d, Minolta, Tokyo, Japan)를 이용하여 L(명도), a(적색도), b(황색도), ΔE(color difference)값으로 표현하였으며 각 시료당 5회 반복 측정하여 평균값으로 나타내었다. 이 때 사용된 표준 백색판의 L, a, b값은 각각 96.97, -0.07, -0.18이었다. The pH was measured by centrifuging the sample (4 ° C., 16,000 × g, 20 min) and then using the pH meter (Mettler Delta 320, Mettler-Toledo Ltd., England). Chromaticity measurement was expressed as L (brightness), a (redness), b (yellowness), and Δ E (color difference) using a color difference meter (CM-3500d, Minolta, Tokyo, Japan). Repeated measurements were made as average values. The L, a and b values of the standard white plate used at this time were 96.97, -0.07 and -0.18, respectively.
차이식별검사는 30℃ 저장 기간 중 시제품인 천연조향제 함유 양파농축액의 이취 발생시기 조사를 위하여 저장일수별로 시료를 채취하여 관능검사 시료로 제시하였다. 매번 검사 시 제조 직후 냉동(-80℃) 보관한 양파농축액 시료를 대조구로 하였고 저장시료들과 대조구간의 이취 차이는 7점 척도로 평가하였다(0; 차이 없음, 1; 아주 적은 차이, 2; 약간의 차이, 3; 중간정도의 차이, 4; 상당한 차이. 5; 대단한 차이, 6; 아주 큰 차이). 이때 훈련된 창원대학교 재학생 19명을 관능검사 패널로 선정하여 시행하였다. The differential discrimination test was performed to collect the samples by the storage days to investigate the off-flavor occurrence time of the onion-derived onion concentrate containing the natural flavor during the storage period of 30 ℃. On each test, control samples were prepared from onion concentrate samples frozen (-80 ° C) immediately after preparation, and the off-flavor difference between the storage samples and the control samples was evaluated on a 7-point scale (0; no difference, 1; very small difference, 2; slightly Difference; 3; moderate difference; 4; significant difference; 5; great difference; 6; very large difference). Nineteen trained students from Changwon National University were selected as sensory test panels.
본 발명의 양파농축액을 30℃에서 120일간 저장동안의 pH 변화는 4.40± 0.0~4.46± 0.0 범위로 거의 변화가 없었다. 시제품의 저장기간 동안 색도 변화는 L값, a값, b값의 변화 정도가 저장기간에 따라 다소 증가 및 감소의 형태를 반복하면서 약간의 변화는 있었으나 ΔE 값에 있어 유의적 변화가 나타나지 않아 저장 120일까지는 색의 변화가 거의 없었던 것으로 보인다.The pH change during storage of onion concentrate of the present invention at 30 ° C. for 120 days was almost unchanged in the range of 4.40 ± 0.0 ~ 4.46 ± 0.0. During the storage period of the prototype, the change of chromaticity was slightly changed as L, a and b values gradually increased and decreased with the storage period, but there was no significant change in the ΔE value. There seems to be little change of color until the day.
30℃ 저장 기간 중 시제품인 천연조향제 함유 양파농축액의 이취 발생시기 조사를 위해 색, 향, 맛, 점도에 대하여 차이식별검사를 실시한 결과는 표 11와 같다. In order to investigate the off-flavor occurrence time of natural concentrate-containing onion concentrate during the storage period of 30 ℃, the results of the difference identification test on color, flavor, taste and viscosity are shown in Table 11.
색, 향, 맛, 점도의 0일차 시료와의 차이정도는 저장 기간에 따라 각각 0.0~1.53, 0.89~1.68, 0.79~2.53, 0.21~1.53 사이에서 다소 증가 및 감소의 형태를 반복하며 약간의 변화를 보였다. 전반적으로 저장기간 동안의 색, 향, 맛, 점도는 3점 이하로 품질저하 현상이 보이지 않았다. The degree of difference in color, aroma, taste, and viscosity from
결과적으로 본 발명에 따른 양파농축액은 30℃에서 120일간 저장하는 동안 pH, 색도, 관능특성인 색, 향, 맛, 점도의 변화가 거의 없이 품질이 유지 되었다.As a result, the onion concentrate according to the present invention was maintained in quality without any change in pH, chromaticity, color, aroma, taste, viscosity during storage for 120 days at 30 ℃.
<< 실험예Experimental Example 3> 양파농축액의 기능성 측정 3> Functional measurement of onion concentrate
3-1. 양파농축액의 3-1. Of onion concentrate 디페닐Diphenyl 피크릴히드라질Picrylhydrazil 자유기 Free period 소거능Scavenging power 측정 Measure
양파농축액의 항산화 활성으로서, 디페닐 피크릴히드라질 자유기 소거능 (2,2-diphenyl-1-picrylhydrazyl radical scavenging effect)을 측정하였다.As antioxidant activity of onion concentrate, diphenyl picrylhydrazyl free group scavenging activity (2,2-diphenyl-1-picrylhydrazyl radical scavenging effect) was measured.
디페닐 피크릴히드라질 자유기 소거능 측정은 Blios 방법에 의해 측정하였다. 즉 시료 0.2mL에 0.2mM 디페닐 피크릴히드라질(DPPH) 0.8mL와 에탄올 2.9mL를 첨가 후 균일하게 혼합한 다음 실온에서 10분간 방치한 후 525nm에서 흡광도를 측정하였다. Diphenyl picrylhydrazyl free group scavenging activity was measured by the Blios method. That is, after adding 0.8 mL of 0.2 mM diphenyl picrylhydrazyl (DPPH) and 2.9 mL of ethanol to 0.2 mL of the sample, the mixture was uniformly mixed and allowed to stand at room temperature for 10 minutes, and then absorbance was measured at 525 nm.
양파농축액은 저장 100일까지 87~94%의 높은 소거능을 가졌고 150일 이후에는 다소 활성이 감소하여 81~85%의 활성을 나타내었다.Onion concentrate had high scavenging ability of 87 ~ 94% until
3-2. 양파농축액의 3-2. Of onion concentrate 과산소디스뮤타제Peroxide dismutase 활성 측정 Active measurement
생체내에는 활성산소에 의한 강한 산화력으로 생리적 장해를 일으킨다. 즉 산소는 1가 환원 반응시 중간 반응 물질로서 O2 -, H2O2, OH-이 생성되며 생체내 항산화 효소에 의해 체내에 무독한 물이 생성된다. 항산화 효소 중 과산소디스뮤타제(superoxide dismutase, SOD)는 O2 -, 를 H2O2로 전환시키는 촉매효소로 활성 산소에 대한 방어기작으로 중요한 역할을 한다. In vivo, physiological disorders are caused by the strong oxidative power of free radicals. In other words the oxygen O 2 as an intermediate after the first reaction material is reduction -, H 2 O 2, OH - are generated, and the generated water is a non-toxic in vivo by in vivo antioxidant enzymes. Among the antioxidant enzymes, superoxide dismutase (SOD) is a catalytic enzyme that converts O 2 - to H 2 O 2 and plays an important role as a defense against free radicals.
이러한 과산소디스뮤타제의 활성은 Marklund 등의 방법을 변형한 과산소디스뮤타제 유사활성을 측정하였다. 즉 시료액 0.2mL에 트리스-염산 완충액(tris-HCl buffer, pH 8.5) 3mL, 7.2mM 피로가롤(pyrogallol) 0.2mL 첨가한 다음 25℃, 10분간 방응시킨 후 1N 염산를 첨가하여 반응을 정지시킨 후 420nm에서 흡광도를 측정하였다. 색소에 영향을 미치는 시료에는 피로가롤 대신에 완충액만 넣고 흡광도를 측정하였다. The peroxide dismutase activity was measured by measuring the peroxide dismutase-like activity modified by Marklund et al. That is, 3 mL of tris-HCl buffer (pH 8.5) and 0.2 mL of 7.2 mM pyrogallol were added to 0.2 mL of the sample solution, followed by reaction at 25 ° C. for 10 minutes, and then 1N hydrochloric acid was added to stop the reaction. After absorbance at 420nm was measured. In the sample affecting the pigment, only the buffer solution was used instead of the pyrroga roll and the absorbance was measured.
양파농축액은 저장기간 동안 40~49%의 과산소디스뮤타제 유사활성능을 유지하였다. Onion concentrate maintained 40-49% peroxide dismutase-like activity during storage.
건강한 여대생들 14명을 대상으로 4주간 매일 100 ㎖의 본 발명의 양파농축액을 섭취하게 한 결과, 과산소디스뮤타제 활성은 섭취 전 1148.60± 50.55에서 섭취 후 1280.89± 39.29로 양파농축액 섭취군에서 유의적으로 증가하여 긍정적인 결과를 보였다. As a result of ingesting 100 ml of the onion concentrate of the present invention daily for four weeks in 14 healthy female college students, the peroxide dismutase activity was significantly increased in the onion concentrate intake group at 1280.89 ± 39.29 after ingestion at 1148.60 ± 50.55 before ingestion. Increasingly, the results were positive.
3-3. 양파농축액의 크산틴 3-3. Xanthine in onion concentrate 옥시다제Oxidase 저해활성측정 Inhibitory Activity Measurement
통풍은 관절에 심한 염증이 되풀이하여 생기는 유전성 대사이상질환으로 관절 속이나 주위에 요산염이 쌓여서 일어난다. 통풍을 일이키는 효소로 크산틴 옥시다제(xanthine oxidase)는 크산틴(xanthine) 또는 히포크산틴(hypoxathine)으로부터 요산(uric acid)를 생성하여 통증을 유발 시키는 것으로 알려져 있다.Gout is a hereditary metabolic disorder caused by repeated inflammation of the joints, which is caused by the accumulation of urate in and around the joints. Xanthine oxidase is an enzyme that causes gout and is known to cause pain by producing uric acid from xanthine or hypoxathine.
본 실험에서는 이러한 크산틴 옥시다제 저해활성을 측정하였다. 실험방법은 Stripe와 Della Corte의 방법을 변형하여 실시하였다. 즉 pH7.5로 조절된 0.1 M 칼슘인산 완충액(potassium phosphate buffer) 0.5 mL에 2 mM 크산틴 1.0 mL, 40mU/mL 크산틴 옥시다제 0.1 mL, 시료 0.5 mL를 순서대로 첨가 한 다음 37 ℃ 3분간 반응 시킨 후 1N 염산으로 반응을 정지 시킨 다음 292 nm에서 흡광도를 측정하였다.In this experiment, xanthine oxidase inhibitory activity was measured. Experimental method was carried out by modifying the method of Stripe and Della Corte. That is, 1 mL of 2 mM xanthine, 0.1 mL of 40mU / mL xanthine oxidase, and 0.5 mL of sample were added to 0.5 mL of 0.1 M calcium phosphate buffer adjusted to pH 7.5, followed by 3 minutes at 37 ° C. After the reaction, the reaction was stopped with 1N hydrochloric acid, and the absorbance was measured at 292 nm.
본 실험의 양파농축액은 14~16%정도로 항통풍성의 효능을 가졌다가 저장일에 따라 서서히 감소하여 저장 150일에 9~12%의 효능을 나타내었다. The onion concentrate of this experiment had anti-gout efficacy at 14 ~ 16%, and gradually decreased according to storage days, showing 9 ~ 12% efficacy at 150 days of storage.
3-4. 양파농축액의 항균활성 측정3-4. Antimicrobial Activity of Onion Concentrate
항균 활성의 측정은 최소 저해 농도(minimum inhibitory concentration, MIC)를 측정하는 액체배지 희석법으로 측정하였다. 즉 시험관에 1 mL의 배지를 넣고 시료 1mL를 첨가하였다. 배지와 시료가 혼합된 시험관을 잘 혼합한 후 혼합액의 1mL를 취하여 1mL의 물러-힌턴 브로스(또는 영양배지) 배지를 포함한 시험관에 넣어 반복한다. 이렇게 준비된 시험관에 균의 농도가 106~107 CFU/mL된 균체 배양액을 0.1 mL 접종한 후 배양하였다(35℃, 18시간). 배양 후 660nm에서 흡광도를 측정하여 균의 증식이 완전히 억제된 농도를 최소 저해 농도 값으로 결정하였다Antimicrobial activity was measured by liquid media dilution, which measures the minimum inhibitory concentration (MIC). That is, 1 mL of medium was added to a test tube, and 1 mL of sample was added thereto. After mixing the test tube mixed with the medium and the sample well, take 1 mL of the mixed solution and repeat in a test tube containing 1 mL Muller-Hinton broth (or nutrient medium) medium. The test tube prepared in this way was inoculated with 0.1 mL of the cell culture solution having a concentration of 10 6 to 10 7 CFU / mL and cultured (35 ° C., 18 hours). After cultivation, the absorbance was measured at 660 nm, and the concentration at which bacterial growth was completely inhibited was determined as the minimum inhibitory concentration value.
본실험의 양파농축액은 그람양성균 바실러스 세레우스(Bacillus cereus), 스타필로코카스 아우레우스(Staphylococcus aureus), 리스테리아 모노시토젠( Listeria monocytogenes), 그람 음성균 에스체르치아 콜라이(Escherichia coil), 살로넬라 티피뮤리움(Salmonella typhimurium), 엔테로박터 에어로젠(Enterobacter aerogenes) 및 곰팡이 아스퍼르질러스 프라버스(Aspergillus flavus), 아스퍼르질러스 나이거(Aspergillus niger)에 대한 항균활성이 검출되지 않았다.Onion concentrate of this experiment is Gram-positive bacteria Bacillus cereus (Bacillus cereus ) , Staphylococcus aureus ) , Listeria monocytogen ( Listeria monocytogenes ) , Gram-negative bacteria Escherichia coli coil), Salo Nella typhimurium (Salmonella typhimurium ) , Enterobacter aerogen aerogenes ) And Aspergillus fungus spread reujil Russ Pradesh bus (Aspergillus flavus ) , Aspergillus niger ), no antimicrobial activity was detected.
3-5. 양파농축액의 3-5. Of onion concentrate 항돌연변이성Antimutagenicity 측정 Measure
항돌연변이 실험방법(Ames Test)는 살로넬라 티피뮤리움(Salmonella typhimurium)의 돌연변이를 이용하여 인공적으로 유발한 돌연변이체(히스티딘이 필요한 개체)를 히스티딘이 없는 배지에서 배양하여 여러 돌연변이원(mutagen)이라 여겨지는 화학물질을 첨가해 배양했을 때, 생성되는 콜로니를 자연적으로 유발되는 복귀 콜로니와 비교하여 돌연변이여부를 판단하는 검증방법으로, 본실험의 양파농축액은 항돌연변이 효과를 나타내지 않았다. The anti-mutation test method (Ames Test) is a multi-mutagen by culturing artificially induced mutants (individuals requiring histidine) using a mutation of Salmonella typhimurium in a histidine-free medium. When cultured with the considered chemicals, the resulting colonies were compared with the naturally occurring return colonies to determine whether they were mutated. Onion concentrates of this experiment did not show antimutagenic effects.
<< 실험예Experimental Example 4> 양파농축액의 고지혈증 완화 효과 4> Alleviate the hyperlipidemia of onion concentrate
4-1. 고기능성 양파농축액 시료 준비 및 4-1. High functional onion concentrate sample preparation and 동물식이Animal diet 준비 Ready
실험에 사용된 양파농축액은 본 발명의 제조방법에 따라 제조된 농축액으로 농축액을 냉동 저장 보관하면서 실험동물에 공급하였다.The onion concentrate used in the experiment was supplied to the experimental animals while freezing and storing the concentrate as a concentrate prepared according to the production method of the present invention.
동물실험에 사용된 식이는 미국영양학회(American Institute of Nutrition, AIN)가 추천하는 표준식이인 분말형 AIN-93G 식이[중앙실험동물(주)]를 사용하였다. 이 AIN-93G 식이의 mineral 함량은 egg white로 조정(표 15 참조)이 되었다. 그리고 고지방식이를 만들기 위해서 AIN-93 식이에 lard(100 g/kg diet)와 cholesterol(7 g/kg diet)를 추가, 혼합하여 준비를 하였다. 최종적으로 조성된 식이표는 표 15와 같다.The diet used in the animal experiment was a powdered AIN-93G diet [Central Laboratory Animal Co., Ltd.], a standard diet recommended by the American Institute of Nutrition (AIN). The mineral content of this AIN-93G diet was adjusted to egg white (see Table 15). In addition, lard (100 g / kg diet) and cholesterol (7 g / kg diet) were added to the AIN-93 diet and mixed to prepare a high fat diet. The final dietary table is shown in Table 15.
기본식이 및 조성은 AIN 추천에 따라 Dyets, Bethlehem, PA 부터 공급되었으며, 조성물에는 0.02% tert-butylhydroquinone이 함유됨. The basic diet and composition were supplied from Dyets, Bethlehem, PA as recommended by AIN, and the composition contained 0.02% tert-butylhydroquinone.
4-2. 고기능성 양파농축액 투여4-2. High functional onion concentrate administration
고기능성 양파농축액의 실험동물 투여는 실험동물이 매일 먹는 물을 통해서 실시하였다. 보다 안전하고 자연스러운 방법으로 자발적으로 동물이 매일 먹는 물병을 통해서 투여하였다. 방법은 우선 실험동물의 1 주일간의 물 섭취량을 측정한 후, 일일 섭취량 (daily intake amount, mL/day)를 구하였다. 그리고 이 물을 매개체로 하여 고기능성 양파농축액을 희석하여 공급하였다. 양파농축액 투여량의 계산은 사람-동물 body surface area(BSA, m2) 비로 계산하였다. 즉, 성인(70 kg 몸무게와 키 173 cm를 기준)의 평균 BSA은 약 1.844 m2이고, 300 grams 흰쥐의 BSA가 약 0.040 m2인 것을 감안할 때, 계산된 사람과 흰쥐의 BSA비가 약 '46'이 되었다. 인체실험에서 현재 매일 고기능성 양파농축액 1 봉지(150 mL)를 제공하기 때문에, 46 배 비율에 해당되는 ‘3.26 mL’가 ‘동물 equivalent’가 되므로, 고기능성 양파농축액이 고지방식이 급여로 유도된 고지혈 동물의 혈중 및 조직의 cholesterol 및 중성지방 함량에 미치는 연구는 사람의 1/2봉지(75 mL)에 해당하는 양(1.63 mL/rat), 사람의 1봉지(150 mL)해당하는 양(3.26 mL/rat), 그리고 2봉지(300 mL)에 해당하는 양(6.52 mL/rat)을 각각 저농도군(low dose), 중농도군(medium dose), 고농도군(high dose)의 동물에 매일 공급하였다. 1 주간에 걸쳐 계산된 하루 평균 실험동물의 평균 물 섭취량이 약 25 mL으로 측정되어, 실험동물이 매일 섭취하는 물 25 mL당 상기된 양파농축액을 희석, 매일 신선하게 공급하였다.Experimental animal administration of high functional onion concentrate was carried out through the water that the experimental animals consume daily. In a safer and more natural way, the animals were spontaneously administered via a water bottle daily. The method first measured the water intake of a week for the experimental animals, and then calculated the daily intake amount (mL / day). And this water was used as a medium to supply a high functional onion concentrate diluted. The onion concentrate dose was calculated from the human-animal body surface area (BSA, m 2 ) ratio. That is, given that the average BSA for adults (based on 70 kg weight and 173 cm in height) is about 1.844 m 2 , and the 300 grams BSA is about 0.040 m 2 , the calculated BSA ratios for humans and rats are about '46. 'Became. Since the human body currently provides 1 bag (150 mL) of high functional onion concentrate daily, the 46-fold ratio '3.26 mL' becomes 'animal equivalent', so the high functional onion concentrate is derived from high fat diet. Studies on the cholesterol and triglyceride content of blood and tissues in hyperlipidemic animals include the equivalent of 1/2 bag (75 mL) of human (1.63 mL / rat) and the equivalent of 1 bag (150 mL) of human (3.26 mL / rat, and 2 bags (300 mL) of the amount (6.52 mL / rat) were fed daily to the low, medium, and high dose animals, respectively. . The average water intake of the average daily experimental animal calculated over a week was measured to be about 25 mL, so that the onion concentrate was diluted and supplied freshly every 25 mL of water the experimental animal consumed daily.
4-3. 동물사육4-3. Animal breeding
실험에 사용된 동물은 male Sprague-Dawley rat(Harlan Sprague Dawley, Inc, 중앙실험동물)이며, 창원대학교 식품영양학과 동물사육실(실내온도 22 ± 2℃, 상대습도 55 ± 5%, 12 h light-dark cycle)에서 사육하였다. 실험식이 공급 전날 체중에 따른 난괴법으로 8마리씩 5군으로 나누어, 개별적 cage에서 사육되었다. 양파농축액이 전혀 공급되지 않고 고지방식이만 공급받는 동물군을 비교군(C, control)으로 하며, 양파성분이 제외되고 기타 성분(양파를 제외한 기타 첨가제 및 향미 성분)만 고지방식이와 함께 공급받는 동물군을 위약군(Placebo)으로 하고, 그리고 고지방식이와 함께 공급되는 양파농축액의 양에 따라 저농도군(low dose), 중농도군(medium dose), 그리고 고농도군(high dose)으로 나누어 6주 동안 공급되었다.The animals used in the experiment were male Sprague-Dawley rats (Harlan Sprague Dawley, Inc, Central Experimental Animals), and the Animal Feeding Dept. of Food and Nutrition, Changwon National University, were raised in a dark cycle. The diet was divided into 5 groups of 8 eggs by the weight of egg mass according to the day before feeding. Animal group that is not supplied with onion concentrate at all and is fed only high fat diet is control group (C, control), except onion ingredient and supplies only other ingredients (other additives and flavors except onion) with high fat diet The receiving group was placed in placebo and divided into low, medium, and high doses for 6 weeks, depending on the amount of onion concentrate supplied with the high fat diet. Was supplied during.
4-4. 체중 증가량 측정 및 혈청 시료 채취4-4. Weight gain measurement and serum sampling
동물의 체중 변화량을 측정하기 위해서 매주 각 동물의 체중을 정해진 시간에 6 주에 걸쳐 측정하였다. 고기능성 양파농축액 투여가 6 주 동안의 실험동물의 체중증가에 미치는 영향은 아래 표 16에서와 같이 비교군과 실험군들과의 비교에서 각 주에서, 6주 동안에 고기능성 양파농축액 투여에 의한 유의적인 차이가 발생하지 않았다. 그리고 양파농축액의 투여량을 증가시키더라도 체중의 변화에 영향을 주지 않았다.In order to measure the weight change of the animals, the weight of each animal was measured every week over 6 weeks at a fixed time. The effect of high functional onion concentrate on the weight gain of experimental animals for 6 weeks was significantly influenced by high functional onion concentrate administration for 6 weeks in each week in comparison with the control group and the experimental groups as shown in Table 1-6 below. No difference occurred. Increasing the dose of onion concentrate did not affect the weight change.
데이터값은 평균 및 표준편차로 표기함(n = 8). C는 대조군(control), P는 위약군(placebo), L은 저용량(low-dose, 15brix 75ml/day), M은 중간용량 (medium-dose, 15brix 150ml/day), H는 고용량(high dose, 15brix 300ml/day) 을 의미한다. Data values are expressed as mean and standard deviation (n = 8). C is control, P is placebo, L is low-dose (15brix 75ml / day), M is medium-dose, 15brix 150ml / day, H is high dose 15brix 300ml / day).
4-5. 혈액 분석4-5. Blood analysis
혈액의 각종 지방의 변화를 측정하기 위해서 안구혈액채취법(retro orbital sinus bleeding)을 이용하여, 실험 식이를 공급하기 직전(0 주)에, 그리고 3 주 째, 그리고 마지막으로 동물을 희생시키면서 6 주 째 시점에서 혈액을 채취하였다. 채취된 혈액은 혈액응고 시간을 가진 후에 원심분리기(2,000 x g for 10 min)를 이용, 혈청시료를 분리하였다. 분리된 혈청으로 즉각 HDL-cholesterol을 분석하였으며, 나머지 혈청은 기타 성분 분석 시까지 -70℃에 보관하였다. 혈액 채취 전에 물만 제외하고 약 16시간 절식시켰다.Using retro orbital sinus bleeding to measure changes in various fats in the blood, just before feeding the experimental diet (week 0), at
혈청의 HDL-콜레스테롤 및 총 콜레스테롤 농도는 효소비색법(아산제약)으로 측정하였다. 총 콜레스테롤의 경우, 혈청 시료 0.10 mL에 조제한 반응시약 3 mL 씩을 첨가하여 흡광도(550 nm)를 측정하고 콜레스테롤 표준용액을 이용하여 시료와 동일한 조건에서 발색시켜 흡광도를 측정, 농도를 계산하였다. 혈청 HDL-콜레스테롤은 먼저 HDL 분획을 분리, 침전시킨 후, 상기한 효소비색법(아산제약)을 이용, 측정하였다. 그리고 혈청의 중성지방(triglycerides) 농도는 효소비색법을 이용한 kit(아산제약)을 사용해서, 발색을 시킨 후에 500 nm에서 흡광도를 측정, 양을 계산하였다.HDL-cholesterol and total cholesterol levels of serum were measured by enzyme colorimetric method (Asan Pharmaceuticals). In the case of total cholesterol, absorbance (550 nm) was measured by adding 3 mL of the reaction reagents prepared in 0.10 mL of the serum sample, and the absorbance was measured under the same conditions as the sample using the cholesterol standard solution, and the concentration was calculated. Serum HDL-cholesterol was measured by first separating and precipitating the HDL fraction and then using the enzyme colorimetric method (Asan Pharmaceutical Co., Ltd.) described above. Serum triglycerides concentration was calculated by measuring the absorbance at 500 nm after color development using kit (Asan Pharmaceuticals) using enzyme colorimetric method.
TG는 triglycerides, C는 cholesterol을 각각 의미한다. 데이터값은 평균 및 표준편차로 표기함(n = 8). C는 대조군(control), P는 위약군(placebo), L은 저용량(low-dose, 15brix 75ml/day), M은 중간용량(medium-dose, 15brix 150ml/day), H는 고용량(high dose, 15brix 300ml/day) 을 의미한다. TG stands for triglycerides and C stands for cholesterol. The data value is Expressed as mean and standard deviation (n = 8). C is control, P is placebo, L is low-dose (15brix 75ml / day), M is medium-dose, 15brix 150ml / day, H is high dose 15brix 300ml / day).
6 주 째에 나타난 혈중 중성지방 농도는 대조군, placebo군, 저농도, 중농도, 고농도 동물군에서 각각 136.2 ± 33.5 mg/dL, 119.3 ± 35.1 mg/dL, 52.0 ± 14.3 mg/dL, 72.4 ± 12.4 mg/dL, 그리고 73.8 ± 25.0 mg/dL으로 나타났다. Blood triglyceride levels at
이러한 결과는 중성지방의 농도가 대조군에 비해서 고지방식이에 의해서 유의적으로 증가되었으나 고기능성 양파농축액 급여군에서와 같이 증가된 농도가 양파농축액 투여에 의해서 유의적으로 감소되었음을 볼 수 있었다. 그러나 저농도, 중농도, 고농도 동물군 사이에서는 유의적인 차이가 발생하지 않았다. 도 4에서 보여지는 바와 같이 3 주 째에는 그룹 간에는 유의적인 차이가 뚜렷하지 않았으나 6 주 째부터 양파농축액 급여에 의한 유의적인 효과가 나타났다.These results showed that the concentration of triglyceride was significantly increased by the high fat diet compared to the control group, but the increased concentration was significantly decreased by the onion concentrate administration as in the high functional onion concentrate feeding group. However, there was no significant difference between low, medium and high animal groups. As shown in FIG. 4, there was no significant difference between the groups at the 3rd week, but from the 6th week, there was a significant effect by the onion concentrate supplement.
6 주 째의 혈청의 총콜레스테롤(total cholesterol) 농도는 대조군, placebo군, 저농도, 중농도, 고농도 동물군에서 각각 170.1 ± 19.1 mg/dL, 151.3 ± 25.4 mg/dL, 109.4 ± 20.4 mg/dL, 113.7 ± 18.3 mg/dL, 그리고 123.7 ± 21.3 mg/dL으로 나타났다. 혈중 중성지방의 농도변화와 유사하게 3 주 째는 각 그룹간에 유의적인 차이가 뚜렷하지 않았으나, 시간이 지나면서 6 주 째는 양파농축액을 공급받은 동물군에서는 그렇지 않은 동물군들에 비해서 유의적인 혈중 총콜레스테롤 감소 효과가 있었다.(도 5)Total cholesterol levels in serum at
표 17에서와 같이, HDL-cholesterol 농도는 대조군이 29.5 ± 9.8 mg/dL이고, placebo군이 26.8 ± 4.5 mg/dL이며, 저농도 양파농축액 투여군이 22.3 ± 6.9 mg/dL로 비교군에 비해서 다소 감소하는 경향을 보였으나, 고농도의 경우에는 유의적인 차이가 없었다. 혈중 non-HDL(공복인 혈액인 경우, non HDL-cholesterol은 대부분 LDL) 콜레스테롤 농도는 대조군이 140.6 ± 17.2 mg/dL이고, palcebo군이 124.5 ± 23.0 mg/dL이며, 고기능성 양파투여군이 저농도, 중농도, 고농도에서 각각 87.1 ± 18.8 mg/dL, 90.6 ± 18.6 mg/dL, 89.0 ± 25.3 mg/dL으로 나타나 두 대조군과 실험군 사이에 유의적인 차이점이 뚜렷하게 나타났다. As shown in Table 1-7, the HDL-cholesterol concentration was 29.5 ± 9.8 mg / dL in the control group, 26.8 ± 4.5 mg / dL in the placebo group, and 22.3 ± 6.9 mg / dL in the low-concentration onion concentrate group compared to the comparison group. In case of high concentration, there was no significant difference. Non-HDL (fasting blood, non-HDL-cholesterol is mostly LDL) cholesterol levels were 140.6 ± 17.2 mg / dL in the control group, 124.5 ± 23.0 mg / dL in the palcebo group, low concentrations in the high-functional onion administration group, At medium and high concentrations, 87.1 ± 18.8 mg / dL, 90.6 ± 18.6 mg / dL, and 89.0 ± 25.3 mg / dL, respectively, showed significant differences between the two groups.
즉 실험결과 고기능성 양파농축액을 6 주 동안 고지방식이와 공급하였을 때, 혈중 중성지방(triacylglycerol)이 유의적으로 감소하며, 이는 본 발명에 따른 양파농축액이 고중성지방혈증(hypertriacylglycerolemia)의 예방 및 치료, 개선을 위한 의약조성물 또는 건강기능식품으로 사용될 수 있음을 보여준다. In other words, when the high-functional onion concentrate was supplied with a high fat diet for 6 weeks, triacylglycerol in blood was significantly reduced, which means that the onion concentrate according to the present invention prevents hypertriacylglycerolemia and It can be used as a pharmaceutical composition or health functional food for treatment, improvement.
같은 조건에서 고기능성 양파농축액을 6 주간 실험동물에 공급했을 때, 고콜레스테롤혈증(hypercholesterolemia)이 유도된 동물에서 양파농축액에 의해서 혈액의 콜레스테롤 농도가 유의적으로 감소되는 것을 확인하였으며, 이는 본 발명이 고지방혈증을 완화하는 효과를 가짐을 나타내고 있으며, 보다 더 장기적으로 지속적으로 고기능성 양파농축액을 복용을 할 경우에 완화효과가 더욱 더 뚜렷할 것으로 기대가 된다.When the high functional onion concentrate was supplied to the experimental animals for 6 weeks under the same conditions, it was confirmed that the cholesterol concentration of blood was significantly decreased by the onion concentrate in the animals induced with hypercholesterolemia. It has been shown to have the effect of alleviating hyperlipidemia, and it is expected that the alleviation effect will be even more pronounced if the high-performance onion concentrate is taken for a longer period of time.
4-6. 임상시험4-6. Clinical trial
고콜레스테롤혈증 환자에서 양파즙의 섭취가 혈중지질 및 항산화체계에 미치는 영향에 대하여 연세대학교 의과대학 세브란스병원에서 임상시험을 실시하였다.The effect of onion juice on blood lipid and antioxidant system in patients with hypercholesterolemia was studied at Severance Hospital of Yonsei University College of Medicine.
혈중 LDL 콜레스테롤이 220~240mg/dL 인 평균연령은 45.85 ± 9.98세의 총 27명(남성 10명, 여성 17명)의 고콜레스테롤혈증 환자(평균 혈중콜레스테롤 값 :228.6 ± 4.11)를 대상으로 본 발명에 따른 0.5%의 천연조향제를 함유한 15브릭스의 양파농축액을 일일 300g 분량을 섭취토록 하는 randomized single blind placebo controlled cross-over design 연구로, 실험시작 전 1주간 의 wash out 기간 후 위약즙을 10주간 섭취하고 다시 1주간의 wash out 기간 후 두 군을 교차시켜 본 발명의 양파농축액을 10주간 섭취하는 총 22주간의 실험이며, 실험 0주, 10주, 11주, 21주째 혈액 및 소변을 채취하여 혈중지질분석치 (총콜레스테롤, HDL 콜레스테롤, 중성지방)와 항산화능 평가지표 (혈장TRAP, 과산화지질, 항산화 비타민 및 적혈구 항산화 효소, 소변내 손상된 DNA배설 8-hydroxydeoxyguanosine측정)를 분석하였다. The mean age of LDL cholesterol of 220 ~ 240mg / dL is 27 patients (10 males, 17 females) with 45.85 ± 9.98 years of age (mean cholesterol level: 228.6 ± 4.11). According to a randomized single blind placebo controlled cross-over design study in which 300 grams of onion concentrate containing 0.5% of natural flavors was consumed daily, placebo juice was added after 1 week of wash out period. After a weekly ingestion and again after a wash out period of one week, the two groups were crossed to ingest the onion concentrate of the present invention for 10 weeks, and a total of 22 weeks of blood and urine were collected at the 0, 10, 11, and 21 weeks of the experiment. Blood lipid analysis (total cholesterol, HDL cholesterol, triglyceride) and antioxidant activity indicators (plasma TAP, lipid peroxidation, antioxidant vitamins and red blood cell antioxidant enzymes, urine damaged DNA excretion 8-hydroxydeoxyguanosine measurement) were analyzed.
조사 대상자들이 Wash-out 기간을 거쳐 0주 때와 10주간의 시료 섭취 후 다시 wash-out 기간을 거치고 cross-over 되는 시점의 혈중 지질 값은 다음 표 18과 같았다. 이때 처음 시료를 10 주간 섭취한 후 뒤에서 볼 수 있듯이 양파농축액을 섭취한 군에서 유의적으로 혈 중 지질 값이 감소하였고, 위약군에서도 유의적이지 않으나 감소된 것을 볼 수 있었는데 이런 원인이 작용하여 cross-over를 시작하는 시점에서 총 콜레스테롤과 HDL- 및 LDL-콜레스테롤 값이 유의적으로 낮은 상태에서 실험이 시작되었다. 이런 현상은 아울러 동맥경화지수인 AI의 값도 유의적으로 낮게 하였다. The blood lipid values of the investigators at the time of the wash-out period and at the 0-week and 10-week intake after the wash-out period and cross-over were shown in Table 18 below. At this time, after taking the first sample for 10 weeks, blood lipids were significantly decreased in the onion-concentrated group and the placebo group was not significant but decreased. At the beginning of over, the experiment began with significantly lower total cholesterol and HDL- and LDL-cholesterol values. This phenomenon also significantly lowered the value of AI, the arteriosclerosis index.
조사 대상자들의 cross-over study에 따른 생화학적 특성을 표 19에 정리하였다.Biochemical characteristics according to the cross-over study of the subjects are summarized in Table 19.
본 발명에 따른 양파농축액 섭취 후 혈중 총 콜레스테롤 농도 및 LDL-콜레스테롤 농도가 유의적으로 감소하여, 고지혈증을 완화시키며 동맥경화지수를 낮추는 것을 확인하였으며, 본 발명에 따른 양파농축액이 혈중지질 및 동맥경화의 예방 및 치료, 개선용 약학조성물 및 건강기능식품으로 사용될 수 있음을 나타낸다. After ingestion of the onion concentrate according to the present invention, blood total cholesterol and LDL-cholesterol concentrations were significantly decreased, thereby relieving hyperlipidemia and lowering the arteriosclerosis index, and the onion concentrate according to the present invention was used for blood lipid and arteriosclerosis. It can be used as a preventive and therapeutic, improving pharmaceutical composition and health functional food.
본 발명에 따른 양파추출농축액은 혈중 중성지방 및 혈중 콜레스테롤을 유의적으로 감소시켜 혈중지질과 동맥경화를 개선시킬 수 있으며, 과산소디스뮤타제 활성을 높이고 크산틴 옥시다제의 활성을 억제함으로써 항산화효과를 가진다.Onion extract concentrate according to the present invention can significantly reduce blood triglycerides and cholesterol in blood to improve blood lipid and arteriosclerosis, increase the peroxide dismutase activity and inhibit the activity of xanthine oxidase Has
본 발명의 양파추출농축액은 천연조향제를 함유하여 양파특유의 불쾌취를 차폐하고 양파즙 농축시 강화되는 단맛을 억제함으로써 산화 관련 질환 및 콜레스테롤 관련 질환의 예방 및 치료를 위한 약학조성물 및 건강기능성 식품으로 유용하게 이용될 수 있다.Onion extract concentrate of the present invention contains a natural flavoring agent to shield the onion's peculiar odor and inhibit the sweetness strengthening when concentrated onion juice concentrate pharmaceutical composition and health functional food for the prevention and treatment of oxidation-related diseases and cholesterol-related diseases It can be usefully used as.
도 1은 본 발명에 따른 양파농축액의 제조공정을 도시한다.1 shows a process for producing an onion concentrate according to the present invention.
도 2는 본 발명에 따른 양파농축액을 30℃에서 120일간 저장동안의 pH 변화를 나타내고, Figure 2 shows the pH change during storage of onion concentrate according to the present invention at 30 ℃ 120 days,
도 3은 양파농축액을 30℃에서 120일간 저장동안의 색 변화를 도시한다.3 shows the color change during storage of onion concentrate at 30 ° C. for 120 days.
도 4는 6주 동안의 고기능성 양파농축액 공급이 흰쥐의 혈액 중성지방(triacylglycerol) 농도에 미치는 영향을 나타내며, Figure 4 shows the effect of high functional onion concentrate supply for 6 weeks on blood triglyceryl concentration of rats,
도 5는 6주 동안의 고기능성 양파농축액 공급이 흰쥐의 혈액 총콜레스테롤 (total cholesterol) 농도에 미치는 영향을 나타낸다.Figure 5 shows the effect of high functional onion concentrate supply for 6 weeks on blood total cholesterol (total cholesterol) concentration of rats.
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080057639A KR100895969B1 (en) | 2008-06-19 | 2008-06-19 | Development of concentrated onion extract having antioxidant and anticholesterol activities |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080057639A KR100895969B1 (en) | 2008-06-19 | 2008-06-19 | Development of concentrated onion extract having antioxidant and anticholesterol activities |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100895969B1 true KR100895969B1 (en) | 2009-05-07 |
Family
ID=40861690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080057639A KR100895969B1 (en) | 2008-06-19 | 2008-06-19 | Development of concentrated onion extract having antioxidant and anticholesterol activities |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100895969B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101453052B1 (en) | 2013-03-15 | 2014-10-23 | 원광대학교산학협력단 | A composition containing onion skin hot water extracts as a active ingredient for the treatment of diabetes mellitus and blood vessel disease |
KR101855821B1 (en) * | 2017-02-28 | 2018-05-10 | 주식회사 진수바이오텍 | Composition for relieving of menopausal symptoms and improving blood circulation |
KR20220060353A (en) | 2020-11-04 | 2022-05-11 | 권천경 | Manufacturing Method for Onion Extracts |
-
2008
- 2008-06-19 KR KR1020080057639A patent/KR100895969B1/en active IP Right Grant
Non-Patent Citations (4)
Title |
---|
Korean J. Food Sci. Technol. 31(6), pp. 1477-1483, 1999. |
Korean J. Food Sci. Technol. 34(2), pp. 330-338, 2002 |
Korean J. Food. Sci. Technol. 37(5), pp. 795-800, 2005 |
Korean J. Pharmacogn. 28(4), pp. 198-208, 1997 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101453052B1 (en) | 2013-03-15 | 2014-10-23 | 원광대학교산학협력단 | A composition containing onion skin hot water extracts as a active ingredient for the treatment of diabetes mellitus and blood vessel disease |
KR101855821B1 (en) * | 2017-02-28 | 2018-05-10 | 주식회사 진수바이오텍 | Composition for relieving of menopausal symptoms and improving blood circulation |
KR20220060353A (en) | 2020-11-04 | 2022-05-11 | 권천경 | Manufacturing Method for Onion Extracts |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2006014028A1 (en) | Sweet potato stem and leaf extract and use thereof | |
C Hunter et al. | Antioxidant and ‘natural protective’properties of kiwifruit | |
KR20060115767A (en) | Physiologically functional drinks and compositions | |
JP4358957B2 (en) | Agent for scavenging or reducing free radicals or active oxygen | |
Tamer et al. | Toxicological aspects of ingredients used in nonalcoholic beverages | |
KR100738658B1 (en) | Composition comprising propolis for producing meat seasoning sauce and method thereof | |
KR100895969B1 (en) | Development of concentrated onion extract having antioxidant and anticholesterol activities | |
KR101559888B1 (en) | Composition for improving hepatoprotective activity comprising fermented garlic extracts | |
KR101394358B1 (en) | Health composition relieving alcohol hangover | |
KR102094084B1 (en) | Aged and complex-fermented mountain-cultivated ginseng having increased ginsenosides of human body absorption type and omega-6 fatty acid, and preparation method thereof | |
Pawłowska et al. | Properties and use of rosemary (L.) | |
KR20170086198A (en) | Manufacturing method of diet solid tea including fermentation herb remedy and dietary fiber and the solid tea produced thereby | |
KR20110123936A (en) | A manufacturing method of functional mul-kimchi using natural herbal materials | |
KR101322279B1 (en) | The beverage containing Gastrodiae rhizoma extract, and manufacturing method thereof | |
C Innocent-Ukachi et al. | Quality evaluation of tea brewed from blends of soursop (Annona muricata) and moringa (Moringa oleifera) leaves | |
KR20220115114A (en) | Extract of Molokhia with high antioxidant effect, and use thereof | |
KR101933043B1 (en) | Method for Manufacturing Soy Sauce Marinated Crab Containing Allium hookeri | |
Marnewick | Antioxidant Properties of Rooibos (Aspalathus linearis)—In Vitro and in Vivo Evidence | |
Ferysiuk et al. | Phytochemical profile of Silybum marianum (L.) Gaertn. and Graminis rhizoma and its influence on the bioactivity and shelf life of industrially produced pâtè | |
KR100880817B1 (en) | The hot sauce containing medicinal herbs | |
JP2006232763A (en) | Bamboo grass extract-containing composition, cosmetic and food and drink containing the same | |
KR20150064521A (en) | Fermented composition comprising bamboo salt and rhynchosia nulubilis | |
KR20040043396A (en) | Functional food composition comprising chitosan, chitosanolig osaccharide and an extract of grapefruit seed having antimicrobial activity | |
KR102392112B1 (en) | Method for producing lactic acid bacteria fermented juice containing apples, beets, and carrots, and Juice prepared by the method | |
KR102414793B1 (en) | A process for the preparation of an onion juice comprising pine needle extracts and the onion juice comprising pine needle extracts prepared therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130401 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140402 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20150429 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170111 Year of fee payment: 8 |
|
R401 | Registration of restoration | ||
FPAY | Annual fee payment |
Payment date: 20180406 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190402 Year of fee payment: 11 |